_id,batch,concept_code,end,inserted_date,job_id,nlpql_feature,owner,phenotype_final,pipeline_id,pipeline_type,report_date,report_id,report_type,sentence,solr_id,source,start,subject,value,value_normalized
5bd1fd3e5d72d26f66ec4dfc,140825,-1,153,2018-10-25 17:28:30.872000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_514536,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Men and women - African American and Hispanic persons age 65 or older - Any person from another ethnic minority group and Caucasian persons age 70 or older - Willing and able to provide informed consent, and willing to accept the study requirements",ct_inc_514536,AACT,98,NCT01038583,Caucasian,white
5bd1fd755d72d27058ec4dfc,59875,-1,44,2018-10-25 17:29:25.258000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_385068,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy Caucasian male subjects, 18-55 years of age - Body Mass Index (BMI) of 17-28 kg/m. -",ct_inc_385068,AACT,30,NCT02731885,Caucasian,white
5bd1fdbb5d72d2720fec4dfc,80750,-1,15,2018-10-25 17:30:35.479000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_335034,Clinical Trial Inclusion Criteria,"Male, Caucasian volunteers, deemed healthy based on a clinical history, physical examination, ECG, vital signs, and laboratory tests of blood and urine.",ct_inc_335034,AACT,0,NCT03383614,Caucasian,white
5bd1fdbc5d72d2720fec4dfd,80750,-1,15,2018-10-25 17:30:36.131000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_335041,Clinical Trial Inclusion Criteria,"Male, Caucasian volunteers, deemed healthy based on a clinical history, physical examination, ECG, vital signs, and laboratory tests of blood and urine.",ct_inc_335041,AACT,0,NCT03383523,Caucasian,white
5bd1fdbc5d72d27204ec4dfc,238025,-1,47,2018-10-25 17:30:36.696000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_556365,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male and female patients(including Hispanic white) greater than or equal to 40 years of age;,ct_inc_556365,AACT,22,NCT00484640,Caucasian,white
5bd1fdf45d72d2735dec4dfc,54900,-1,55,2018-10-25 17:31:32.421000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_425566,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male and female Caucasian subjects as determined by results of screening - Written informed consent in accordance with Good Clinical Practice and local legislation given - Age >= 18 and <= 50 years - Broca >,ct_inc_425566,AACT,30,NCT02203500,Caucasian,white
5bd1fe015d72d27398ec4dfc,2775,-1,22,2018-10-25 17:31:45.322000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_411258,Clinical Trial Inclusion Criteria,Caucasian Healthy male subject.,ct_inc_411258,AACT,0,NCT02390141,Caucasian,white
5bd1fe105d72d273fdec4dfc,185550,-1,46,2018-10-25 17:32:00.301000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_516400,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy, Caucasian, male, adult light to regular smokers",ct_inc_516400,AACT,31,NCT01013454,Caucasian,white
5bd1ffbc5d72d27cdeec4dfc,160225,-1,79,2018-10-25 17:39:08.879000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_444356,Clinical Trial Inclusion Criteria,"The subject is a healthy male or female subject from Caucasian, Japanese, Black/African or Chinese origin.",ct_inc_444356,AACT,25,NCT01958047,Black,black
5bd2019d5d72d2093bec4dfc,184200,-1,37,2018-10-25 17:47:09.950000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_518142,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian, male or females, 50 to 85 years inclusive.",ct_inc_518142,AACT,22,NCT00990613,Caucasian,white
5bd201d85d72d20a76ec4dfc,174800,-1,47,2018-10-25 17:48:08.736000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_468201,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female East Asian patients 18 years or older - Diagnosed Multiple Myeloma according to standard criteria - Measurable disease as specified in study protocol - Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 - Patients with relapsed and/or refractory Multiple Myeloma who have received 1 to 3 prior therapies,ct_inc_468201,AACT,22,NCT01645930,Asian,asian
5bd202835d72d20e87ec4dfc,136025,-1,38,2018-10-25 17:50:59.143000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_480964,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian Female - Natural or surgical menopause between 1 and 5 years - Aged between 50 to 65 years - BMI between 19 and 30 kg/m,ct_inc_480964,AACT,22,NCT01478724,Caucasian,white
5bd2033a5d72d212b6ec4dfc,92800,-1,43,2018-10-25 17:54:02.719000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_350355,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American male identified as at high risk for violence by the Birmingham Violence Reduction Initiative,ct_inc_350355,AACT,22,NCT03184116,African American,black
5bd205065d72d21debec4dfc,189025,-1,21,2018-10-25 18:01:42.140000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_502612,Clinical Trial Inclusion Criteria,Male and female Black / African American patients Diagnosis of type 2 diabetes at least 3 months prior to the informed consent.,ct_inc_502612,AACT,0,NCT01194830,Black,black
5bd205305d72d21ee8ec4dfc,24475,-1,44,2018-10-25 18:02:24.976000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_390367,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy Caucasian male.,ct_inc_390367,AACT,30,NCT02662738,Caucasian,white
5bd2055e5d72d22002ec4dfc,44050,-1,80,2018-10-25 18:03:10.243000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_400059,Clinical Trial Inclusion Criteria,Healthy and free from clinically significant illness or disease - Male Caucasian subjects aged 18 to 55 - A body weight of 60 kg,ct_inc_400059,AACT,66,NCT02536209,Caucasian,white
5bd205b95d72d22221ec4dfc,179150,-1,46,2018-10-25 18:04:41.124000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_525633,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male and female Europeans at the age of 18 years or above with hypertension, metabolic syndrome, and modest inflammation - Blood pressure greater than or equal to 130/85 mmHg AND - hs-CRP greater than or equal to 1.0 and less than 10.0 mg/dL AND at least two (2) of the following traits of the metabolic syndrome (ATP III criteria): - abdominal obesity:",ct_inc_525633,AACT,22,NCT00891267,European,white
5bd206685d72d22657ec4dfc,163575,-1,245,2018-10-25 18:07:36.593000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_438155,Clinical Trial Inclusion Criteria,"Inclusion Criteria Platelet count between the lower limit of normal and 350 x 109/L, inclusive, at Screening and each Baseline; measurements can repeated for verification, if necessary Nonsmoking, healthy white and Japanese adult male and female subjects, greater than or equal to 20 years and less than or equal to 55 years old at the time of informed consent.",ct_inc_438155,AACT,205,NCT02039076,white,white
5bd206ac5d72d2280fec4dfc,182900,-1,44,2018-10-25 18:08:44.926000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_526888,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male non-asian subjects,ct_inc_526888,AACT,30,NCT00874757,asian,asian
5bd206f35d72d229c7ec4dfc,168550,-1,106,2018-10-25 18:09:55.470000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_462813,Clinical Trial Inclusion Criteria,"Inclusion Criteria Caucasian males defined as persons of a European or Latin American descent Healthy male 30 to 55 years inclusive at the time of informed consent Body mass index (BMI) of 18 to 32 kg/m2 at Screening Subjects must have had a successful vasectomy (confirmed azoospermia), or they and their female partners must not be of childbearing potential or must be practicing highly effective contraception throughout the study period and for 30 days after study drug discontinuation.",ct_inc_462813,AACT,59,NCT01716897,European,white
5bd207a95d72d22e3fec4dfc,96300,-1,154,2018-10-25 18:12:57.300000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_344080,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Experiences of intimate partner violence within the past one year - Foreign born immigrant or refugee woman OR Native American woman - 18-64 years of age - Can access and use internet,ct_inc_344080,AACT,133,NCT03265847,Native American,native american
5bd207c55d72d22ef6ec4dfc,155100,-1,56,2018-10-25 18:13:25.532000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_449549,Clinical Trial Inclusion Criteria,"Inclusion Criteria: Male or female patients of Caucasian origin, aged between 18 to 65 years, inclusive, at the time informed consent is obtained.",ct_inc_449549,AACT,20,NCT01890148,Caucasian,white
5bd208505d72d2325bec4dfc,201100,-1,64,2018-10-25 18:15:44.056000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_532644,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Age 18-65 years, male or female, Caucasian or not;",ct_inc_532644,AACT,39,NCT00798785,Caucasian,white
5bd208885d72d233bfec4dfc,180200,-1,35,2018-10-25 18:16:40.562000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_522357,Clinical Trial Inclusion Criteria,"Healthy Japanese and Caucasian male subjects 20 to 45 years of age inclusive - Body weight between 50 and 85 kg, inclusive, with a Body Mass Index (BMI) 19 to 27 kg/m2",ct_inc_522357,AACT,21,NCT00935025,Caucasian,white
5bd209c35d72d23b91ec4dfc,186950,-1,29,2018-10-25 18:21:55.122000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_493894,Clinical Trial Inclusion Criteria,- Male or female of Caucasian or African-American origin.,ct_inc_493894,AACT,2,NCT01308983,Caucasian,white
5bd209d15d72d23be9ec4dfc,169650,-1,82,2018-10-25 18:22:09.302000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_472011,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Signed and dated Informed Consent - Male or female Caucasian patients with stable chronic mild-to-moderate plaque-type psoriasis (PASI 15) aged 18-75 years who must have at least two pronounced but not active lesions of >9 cm2 each, stable for at least 3 months, local PASI score Distance between lesions must be at least 30 cm.",ct_inc_472011,AACT,58,NCT01595997,Caucasian,white
5bd20a5d5d72d23f27ec4dfc,225125,-1,42,2018-10-25 18:24:29.011000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_433553,Clinical Trial Inclusion Criteria,Healthy Caucasian male subjects and female subjects of non-childbearing potential.,ct_inc_433553,AACT,8,NCT02099201,Caucasian,white
5bd20aa75d72d240daec4dfc,128275,-1,25,2018-10-25 18:25:43.636000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_470512,Clinical Trial Inclusion Criteria,"Caucasian, female or male, and aged 18 years to 55 years, inclusive.",ct_inc_470512,AACT,0,NCT01615510,Caucasian,white
5bd20acb5d72d241c8ec4dfc,122425,-1,65,2018-10-25 18:26:19.958000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_594735,Clinical Trial Inclusion Criteria,These will be newborn screening blood spots from African American babies.,ct_inc_594735,AACT,14,NCT00017732,African American,black
5bd20bfe5d72d248cdec4dfc,235550,-1,20,2018-10-25 18:31:26.979000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_542483,Clinical Trial Inclusion Criteria,"Asian male or female subjects between 18 and 49 years of age, who are in good physical health with no significant medical problems or laboratory test abnormalities.",ct_inc_542483,AACT,0,NCT00668902,Asian,asian
5bd20df45d72d25421ec4dfc,139925,-1,44,2018-10-25 18:39:48.610000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_478124,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy Caucasian male subjects, 40-55 years of age.",ct_inc_478124,AACT,30,NCT01515891,Caucasian,white
5bd20e535d72d2566cec4dfc,180075,-1,45,2018-10-25 18:41:23.959000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_519070,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy, caucasian male subjects -",ct_inc_519070,AACT,31,NCT00978302,caucasian,white
5bd20e865d72d257abec4dfc,222625,-1,35,2018-10-25 18:42:14.639000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_459498,Clinical Trial Inclusion Criteria,"Subject is a healthy male Caucasian or Japanese, aged 20 - 45 years, inclusive, at screening.",ct_inc_459498,AACT,21,NCT01760187,Caucasian,white
5bd20e975d72d2580aec4dfc,172150,-1,46,2018-10-25 18:42:31.366000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_464783,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Caucasians aged between 18 and 60 years - Patients with mild atopic dermatitis (AD) presenting a scoring AD (SCORAD) rating below 50 - Skin type I - IV according to Fitzpatrick - Acute AD symptoms on each assessment areas (local SCORAD 3 and <= 12) at Baseline - Acute symptom of pruritus at Baseline,ct_inc_464783,AACT,22,NCT01691209,Caucasian,white
5bd2102b5d72d262bfec4dfc,181950,-1,22,2018-10-25 18:49:15.342000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_521747,Clinical Trial Inclusion Criteria,"Healthy male Caucasian volunteers aged 18-60 years, - BMI of 20-25 kg/m2, - Able to give voluntary written informed consent to participate in the study, - Able to understand the requirements of the study, including anonymous publication, and agree to co-operate with the study procedures.",ct_inc_521747,AACT,8,NCT00943020,Caucasian,white
5bd210985d72d26544ec4dfc,204150,-1,91,2018-10-25 18:51:04.611000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_540202,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Female - Age 45 (inclusive) to 55 years (inclusive) - Race: Caucasian - Non-smokers / Smokers up to 10 cigarettes/day -,ct_inc_540202,AACT,76,NCT00698984,Caucasian,white
5bd210d95d72d266d0ec4dfc,202250,-1,74,2018-10-25 18:52:09.276000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_537383,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male or female - Asian-American, defined as a person of self-reported Asian ancestry who is residing in the United States (US) - 18 through 75 years of age, inclusive - Documented chronic HBV infection, defined as positive serum HBsAg =/>",ct_inc_537383,AACT,39,NCT00736190,Asian,asian
5bd210fd5d72d26784ec4dfc,128650,-1,44,2018-10-25 18:52:45.893000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_473117,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian healthy male - Able to feel a distinct pin-pick sensation on normal skin - Subject willing and able to complete the requirements of this study - Written informed consent signed prior to any study related procedures,ct_inc_473117,AACT,22,NCT01581450,Caucasian,white
5bd211345d72d268bfec4dfc,49625,-1,23,2018-10-25 18:53:40.783000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_427150,Clinical Trial Inclusion Criteria,"- Male and female black/African American patients on diet and exercise regimen who are EITHER drug-nave (defined as absence of any oral antidiabetic therapy, glucagon like peptide-1 (GLP-1) analog or insulin for 12 weeks,",ct_inc_427150,AACT,2,NCT02182830,black,black
5bd211575d72d26989ec4dfc,48675,-1,46,2018-10-25 18:54:15.978000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_428062,Clinical Trial Inclusion Criteria,"Healthy male subjects of Japanese or Caucasian origin according to the following criteria: Based upon a complete medical history, including the physical examination, vital signs (blood pressure, pulse rate, respiratory rate and tympanic body temperature), 12- lead ECG (electrocardiogram), clinical laboratory tests - 1.1 No finding deviating from normal and of clinical relevance - 1.2 No evidence of a clinically relevant concomitant disease Age 20 and Age 45 years Body mass index (BMI) 18 and 25 kg/m2 Japanese subjects were from a well-defined Japanese population, both parents of Japanese origin and the subjects have Japanese passport and had lived 8 years outside Japan.",ct_inc_428062,AACT,8,NCT02170909,Caucasian,white
5bd2118d5d72d26ab2ec4dfc,29900,-1,25,2018-10-25 18:55:09.298000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_384213,Clinical Trial Inclusion Criteria,Male and female Caucasian subjects aged 18 to 55 years inclusive.,ct_inc_384213,AACT,0,NCT02743013,Caucasian,white
5bd211b55d72d26ba4ec4dfc,8475,-1,57,2018-10-25 18:55:49.437000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_418392,Clinical Trial Inclusion Criteria,"Inclusion Criteria for healthy subjects: - Caucasian male subject - 18-35 yrs-old - BMI between 18 and 30 Kg/m2 - Normal biological pattern (sodium, potassium, eGFR >",ct_inc_418392,AACT,43,NCT02297048,Caucasian,white
5bd2130e5d72d27329ec4dfc,29700,-1,36,2018-10-25 19:01:34.537000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_384028,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - caucasian male or females - participants 18 years of age and older - participants with known birch allergy, confirmed by a skin test 3mm or greater than the negative control - participants with diagnosed and confirmed peanut with allergy - confirmed by one of the following: - positive food challenge - convincing history of peanut allergy AND positive skin test (3mm >= than negative control) OR peanut-specific IgE >=0.35 - uncertain history of peanut allergy OR no exposure to peanut AND a positive skin test 5mm>= negative control AND a peanut-specific IgE >=15 - non-allergic controls who lack a diagnosis of any atopic diathesis and have supportive negative skin testing to a panel of common environmental allergens.",ct_inc_384028,AACT,22,NCT02745418,caucasian,white
5bd213465d72d2747bec4dfc,75850,-1,56,2018-10-25 19:02:30.008000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_328879,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Age 60 or greater Caucasian female with confirmed osteoporosis via prior DEXA.,ct_inc_328879,AACT,40,NCT03463850,Caucasian,white
5bd214245d72d27994ec4dfc,224300,-1,273,2018-10-25 19:06:12.265000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_456681,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Subject was informed and given ample time and opportunity to think about his/her participation and had given his/her written informed consent - Subject was willing and able to comply with all trial requirements - Subject was a male or female Caucasian, between 18 and 70 years of age (inclusive) - If female, subject was of non-childbearing potential (post-menopausal or hysterectomized) or was using medically adequate contraception -",ct_inc_456681,AACT,249,NCT01796938,Caucasian,white
5bd214395d72d279fbec4dfc,112075,-1,60,2018-10-25 19:06:33.898000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_568395,Clinical Trial Inclusion Criteria,Male non-Hispanic African-American or non-Hispanic Caucasian patients between 18 and 65 years of age Abstinence from any ingestion of alcohol and smoking for at least 7 days prior to study for those who drink or smoke socially 3.,ct_inc_568395,AACT,0,NCT00324389,Caucasian,white
5bd214a15d72d27c42ec4dfc,111325,-1,78,2018-10-25 19:08:17.013000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_560753,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Female patients fulfilling the current American-European consensus classification criteria.,ct_inc_560753,AACT,22,NCT00426543,European,white
5bd214b15d72d27c9eec4dfc,180100,-1,46,2018-10-25 19:08:33.095000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_519097,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy, Caucasian, male subjects aged 18-45 years inclusive.",ct_inc_519097,AACT,31,NCT00977951,Caucasian,white
5bd214b15d72d27ca1ec4dfc,149275,-1,19,2018-10-25 19:08:33.896000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_512914,Clinical Trial Inclusion Criteria,"Healthy White, male volunteers between 18 and 55 years of age (inclusive).",ct_inc_512914,AACT,8,NCT01059903,White,white
5bd214e45d72d27dc3ec4dfc,173900,-1,45,2018-10-25 19:09:24.330000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_455974,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - African American female, - age 19 - 75yr.:",ct_inc_455974,AACT,22,NCT01806194,African American,black
5bd215725d72d20237ec4dfc,187900,-1,115,2018-10-25 19:11:46.006000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_486439,Clinical Trial Inclusion Criteria,) sex: male and female (non-child-bearing potential or using medically adequate contraception IN.2) race: Caucasian IN.3),ct_inc_486439,AACT,100,NCT01406925,Caucasian,white
5bd2157c5d72d2026aec4dfc,23025,-1,79,2018-10-25 19:11:56.816000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_367660,Clinical Trial Inclusion Criteria,"- Women who are primary female caregivers and self-identify as African American or Black, and are over the age of 18.",ct_inc_367660,AACT,24,NCT02958813,African American,black
5bd216495d72d2070eec4dfc,3400,-1,54,2018-10-25 19:15:21.675000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_420203,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy male or female Caucasian subjects aged 20-60 years - Normal outcome in Pittsburgh Sleep Quality Index (PSQI), below mean +2 Standard Deviation (SDs) -",ct_inc_420203,AACT,30,NCT02273453,Caucasian,white
5bd217435d72d20ce4ec4dfc,40750,-1,177,2018-10-25 19:19:31.741000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_400414,Clinical Trial Inclusion Criteria,"Able and willing to provide written informed consent to participate in this study - Healthy, free from clinically significant illness or disease - White Caucasian male or female, aged 18 to 55 years - Body weight ranging from 50 (females) and 60 (males)",ct_inc_400414,AACT,147,NCT02531568,White,white
5bd217d95d72d21037ec4dfc,148100,-1,43,2018-10-25 19:22:01.564000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_509015,Clinical Trial Inclusion Criteria,Written informed consent - Caucasian female postmenopausal patients - Patients with histologically confirmed primary palpable and nonpalpable breast cancer sized up to 5 cm (T1 - T2),ct_inc_509015,AACT,27,NCT01110954,Caucasian,white
5bd2180a5d72d21138ec4dfc,244875,-1,21,2018-10-25 19:22:50.425000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_570370,Clinical Trial Inclusion Criteria,African American male with newly diagnosed hypertension between age 25 to 59 -,ct_inc_570370,AACT,0,NCT00298207,African American,black
5bd218d05d72d215a1ec4dfc,79950,-1,38,2018-10-25 19:26:08.573000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_333427,Clinical Trial Inclusion Criteria,Aged 18 or older Biological male Black/African American or Hispanic/Latino History of condomless receptive or insertive anal intercourse with other men in the past 6 months,ct_inc_333427,AACT,28,NCT03404531,Black,black
5bd2190e5d72d21705ec4dfc,50375,-1,92,2018-10-25 19:27:10.058000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_427412,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy volunteers Male or female, within 18 and 50 year old Caucasian type No cardiovascular risk factor:",ct_inc_427412,AACT,49,NCT02179411,Caucasian,white
5bd219175d72d21726ec4dfc,126650,-1,53,2018-10-25 19:27:19.093000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_594624,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American male or female aged 30 years or older diagnosed with type 2 diabetes mellitus -,ct_inc_594624,AACT,22,NCT00022750,African American,black
5bd219f15d72d21bf6ec4dfc,222850,-1,277,2018-10-25 19:30:57.483000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_437999,Clinical Trial Inclusion Criteria,Inclusion Criteria are parameters used for metabolic syndrome determination according to International Diabetes Federation (IDF) consensus worldwide definition of Metabolic Syndrome: Participant must have central obesity: defined as waist circumference 80 cm for European woman and 94 cm for European men.,ct_inc_437999,AACT,263,NCT02041104,European,white
5bd21a745d72d21ef5ec4dfc,221550,-1,125,2018-10-25 19:33:08.843000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_411518,Clinical Trial Inclusion Criteria,"Main Inclusion - Subject's written informed consent obtained prior to any study-related procedure - Male and female Caucasian healthy volunteers aged 18-55 years inclusive - Vital signs:Subjects aged 18-45: Diastolic BP 40-90, Systolic BP 90-140 Subjects aged 45-55: Diastolic BP 40-90, Systolic BP 90-150 (as mean of three measures performed after at least 5 minutes of resting); checked at screening visit and Day -1 - 12-lead digitised Electrocardiogram (12-lead ECG) considered as normal (40Heart rate110bpm,120 ms PR 210 ms, QRS 120 ms, QTcF 450 ms for males and 470ms for females) checked at screening visit and Day -1 - Lung function measurements within normal limits:",ct_inc_411518,AACT,100,NCT02386761,Caucasian,white
5bd21b035d72d22226ec4dfc,130375,-1,36,2018-10-25 19:35:31.731000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_449625,Clinical Trial Inclusion Criteria,Healthy male and/or female Caucasian (neither Black/African American nor Japanese) volunteers aged 18-50 years.,ct_inc_449625,AACT,20,NCT01889160,Caucasian,white
5bd21c4e5d72d229b2ec4dfc,145800,-1,38,2018-10-25 19:41:02.564000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_512533,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Female Caucasians between 30 and 55 years of age, with hypotrichosis",ct_inc_512533,AACT,22,NCT01064882,Caucasian,white
5bd21c945d72d22b37ec4dfc,191125,-1,190,2018-10-25 19:42:12.523000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_501921,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Locally advanced or metastatic non-small cell lung cancer (i.e. cancer that has spread from where it started) which is EGFR mutation positive - Caucasian female or male patients aged 18 years or over - Measurable disease, i.e. at least one lesion, not previously irradiated, as 10 mm in the longest diameter ( 15 mm in short axis for lymph node )",ct_inc_501921,AACT,166,NCT01203917,Caucasian,white
5bd21caa5d72d22bc6ec4dfc,94650,-1,58,2018-10-25 19:42:34.410000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_345474,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Age 18-50 years old - Caucasian male volunteers - Body mass index (,ct_inc_345474,AACT,44,NCT03247699,Caucasian,white
5bd21d5e5d72d22fffec4dfc,141900,-1,51,2018-10-25 19:45:34.015000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_515477,Clinical Trial Inclusion Criteria,"Inclusion Criteria - Male or female, black or white with SCI due to a nonvascular insult that caused an acute spinal cord injury (i.e. traumatic injury, transverse myelitis without a diagnosis of multiple sclerosis, surgical complication, or benign neoplasm) at least 1 year prior to enrollment including ASIA A,B,C - Age at time of enrollment: > 38 years and <55 years (i.e., on or after 38th birthday and before 55th birthday) - Voluntary, informed consent of participant - Participant willing to comply with the testing protocols and questionnaires - Communication and comprehension sufficient for compliance with all testing procedures and measures",ct_inc_515477,AACT,21,NCT01025609,white,white
5bd21d905d72d23130ec4dfc,52650,-1,44,2018-10-25 19:46:24.840000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_424404,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male caucasian subjects as determined by results of screening - Written informed consent in accordance with Good Clinical Practice and local legislation given - Age >= 18 and <= 50 years - Broca >,ct_inc_424404,AACT,30,NCT02218684,caucasian,white
5bd21da35d72d2319eec4dfc,146375,-1,90,2018-10-25 19:46:43.174000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_512144,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - 20-25-year-old healthy Volunteers or of 40-50 years, male, Caucasian, - Presenting no disorder of the perception, -",ct_inc_512144,AACT,75,NCT01070004,Caucasian,white
5bd21dc15d72d2324eec4dfc,161550,-1,53,2018-10-25 19:47:13.167000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_447981,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Pregnant American Indian female less than or equal to 32 weeks gestation.,ct_inc_447981,AACT,31,NCT01910701,American Indian,american indian
5bd21e4b5d72d23562ec4dfc,171000,-1,20,2018-10-25 19:49:31.122000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_460756,Clinical Trial Inclusion Criteria,Adult male Caucasian patients aged 18 and 60 years.,ct_inc_460756,AACT,6,NCT01743768,Caucasian,white
5bd21e655d72d235f5ec4dfc,197850,-1,36,2018-10-25 19:49:57.191000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_539554,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male - Age: 25-55 years - Chronic Hepatitis C (PCR positive) and fibrosis F2 (if liver biopsy done) - Genotypes 1 or 3 - Due to commence antiviral therapy - BMI,ct_inc_539554,AACT,22,NCT00707603,Caucasian,white
5bd21ecb5d72d23856ec4dfc,23125,-1,134,2018-10-25 19:51:39.666000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_367769,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male subjects - Age: 18 to 45 years (inclusive) - Body mass index (BMI) : 18 and 29.9 kg/m - Race: White,ct_inc_367769,AACT,123,NCT02957396,White,white
5bd21fb15d72d23da3ec4dfc,195625,-1,127,2018-10-25 19:55:29.650000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_497280,Clinical Trial Inclusion Criteria,"The parent/guardian self-identifies the uninsured child as Hispanic/Latino, African-American/Black, or both The uninsured child is eligible for either Medicaid or CHIP",ct_inc_497280,AACT,93,NCT01264718,Black,black
5bd21fc55d72d23e1cec4dfc,26975,-1,96,2018-10-25 19:55:49.346000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_382011,Clinical Trial Inclusion Criteria,"11.0 g/dL for volunteers who were born female, 13.0 g/dL for volunteers who were born male White blood cell count",ct_inc_382011,AACT,86,NCT02771730,White,white
5bd220085d72d23fbeec4dfc,133125,-1,51,2018-10-25 19:56:56.525000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_485578,Clinical Trial Inclusion Criteria,"= 13.0 g/dL for volunteers who were born male White blood cell (WBC) count = 3,300 to 12,000 cells/mm3 Total lymphocyte count = 800 cells/mm3 Platelets =",ct_inc_485578,AACT,41,NCT01418235,White,white
5bd220dc5d72d244a0ec4dfc,51100,-1,80,2018-10-25 20:00:28.306000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_432848,Clinical Trial Inclusion Criteria,"Inclusion Criteria at Screening East Asian or Caucasian subjects, male or female, and 18 to 40 years of age inclusive Body mass index",ct_inc_432848,AACT,37,NCT02108418,Asian,asian
5bd220e75d72d244d7ec4dfc,247225,-1,45,2018-10-25 20:00:39.210000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_560458,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Europeans aged 18 years or older with moderate to severe hypertension (HTN),ct_inc_560458,AACT,22,NCT00430508,European,white
5bd220e85d72d244e6ec4dfc,151825,-1,189,2018-10-25 20:00:40.675000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_510959,Clinical Trial Inclusion Criteria,"must be Japanese, and subject must have been born in Japan, subjects should usually reside in Japan but can have been resident outside of Japan for up to 5 years), or Healthy male Caucasian volunteers.",ct_inc_510959,AACT,175,NCT01085552,Caucasian,white
5bd221045d72d24592ec4dfc,190675,-1,56,2018-10-25 20:01:08.909000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_502255,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy, Caucasian male and female subjects 20 - 80.",ct_inc_502255,AACT,31,NCT01199549,Caucasian,white
5bd2213d5d72d246cdec4dfc,125850,-1,33,2018-10-25 20:02:05.616000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_592331,Clinical Trial Inclusion Criteria,- African American male or female 18 years or older.,ct_inc_592331,AACT,2,NCT00047775,African American,black
5bd221ba5d72d249afec4dfc,150250,-1,14,2018-10-25 20:04:10.038000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_506305,Clinical Trial Inclusion Criteria,Caucasian male - Age between [18-55] -,ct_inc_506305,AACT,0,NCT01146483,Caucasian,white
5bd221ea5d72d24adcec4dfc,235650,-1,46,2018-10-25 20:04:58.593000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_542277,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Caucasian subjects.,ct_inc_542277,AACT,22,NCT00671619,Caucasian,white
5bd222205d72d24bfaec4dfc,159825,-1,36,2018-10-25 20:05:52.594000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_443982,Clinical Trial Inclusion Criteria,Healthy male and/or female Caucasian (neither Black/African American nor Japanese) volunteers aged 18 to 50 years with suitable veins for cannulation or repeated venipuncture.,ct_inc_443982,AACT,20,NCT01962935,Caucasian,white
5bd2226e5d72d24dccec4dfc,157275,-1,121,2018-10-25 20:07:10.734000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_446081,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Written informed consent has been signed prior to or at Screening Visit - Caucasian male and female patients - Age > 18 years - Negative pregnancy test in women of childbearing age - Clinical diagnosis of actinic keratosis (AK) -,ct_inc_446081,AACT,96,NCT01935531,Caucasian,white
5bd2235f5d72d252f4ec4dfc,46425,-1,89,2018-10-25 20:11:11.190000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_401133,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Self-identified Black, stable, chronic heart failure male or female subjects classified as having New York Heart Association (NYHA) Class II or III, diagnosed at least 3 months prior to Screening. -",ct_inc_401133,AACT,38,NCT02522208,Black,black
5bd223ae5d72d254d8ec4dfc,8125,-1,48,2018-10-25 20:12:30.295000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_418619,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male volunteers, Caucasians, born in the Netherlands - Age: 35-55 years - BMI > 25 and < 32 kg/m2 - plasma glucose levels 2 h after OGTT between 7.8 and 11 mm (e.g. impaired glucose tolerance)",ct_inc_418619,AACT,22,NCT02294084,Caucasian,white
5bd223ae5d72d254d8ec4dfd,8125,-1,36,2018-10-25 20:12:30.715000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_418628,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male aged 30 to 65 at Screening.,ct_inc_418628,AACT,22,NCT02293967,Caucasian,white
5bd224f35d72d25b7aec4dfc,149850,-1,51,2018-10-25 20:17:55.498000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_512665,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - (a) male and female Caucasian volunteers aged 18 years/0 months to 19 years/11 months; - (b) written informed consent by the subject; - (c) habitual social drinking during the two months preceding participation, defined by at least one drinking day in any two weeks-interval; - (d) at least one prior experience of alcohol intoxication - (e) being able to abstain from tobacco use for four hours without developing nicotine withdrawal symptoms; - (f) effective contraception in female participants; -",ct_inc_512665,AACT,26,NCT01063166,Caucasian,white
5bd225705d72d25e57ec4dfc,196950,-1,38,2018-10-25 20:20:00.244000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_535998,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian female - Age,ct_inc_535998,AACT,22,NCT00754442,Caucasian,white
5bd226065d72d261bcec4dfc,155000,-1,83,2018-10-25 20:22:30.927000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_448835,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Ages 18-70 (inclusive) - Sex Male and female - Race Caucasian and African-American/black - BMI 18.-0-29.9 - BP Normal,ct_inc_448835,AACT,69,NCT01899495,Caucasian,white
5bd226585d72d2635eec4dfc,218950,-1,24,2018-10-25 20:23:52.762000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_545633,Clinical Trial Inclusion Criteria,"Caucasian male or female subjects aged between 19-29 months at Screening Visit Born SGA (birth length and/or weight <-2 SD for gestational age, using country-specific standards).",ct_inc_545633,AACT,0,NCT00627523,Caucasian,white
5bd227eb5d72d26c30ec4dfc,179725,-1,59,2018-10-25 20:30:35.785000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_522620,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male and non-fertile female healthy volunteers aged 18 to 55 years with suitable veins for cannulation or repeated venipuncture.,ct_inc_522620,AACT,22,NCT00931541,Caucasian,white
5bd2284b5d72d26e0aec4dfc,55200,-1,14,2018-10-25 20:32:11.706000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_426620,Clinical Trial Inclusion Criteria,"Male Caucasians aged 18 to 55 years, inclusive.",ct_inc_426620,AACT,0,NCT02189733,Caucasian,white
5bd228865d72d26f63ec4dfc,110475,-1,45,2018-10-25 20:33:10.082000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_565536,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female European out-patients - Greater than or equal to 30 years of age - Type 2 diabetes first diagnosed at greater than or equal to 30 years of age - Urinary protein excretion between 200-4000 mg/day exclusive - Mean sitting dBP less than or equal to,ct_inc_565536,AACT,22,NCT00362960,European,white
5bd228895d72d26f8bec4dfc,89775,-1,53,2018-10-25 20:33:13.767000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_314883,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American female or male - Between 15-21 years of age,ct_inc_314883,AACT,22,NCT03646032,African American,black
5bd229285d72d272f4ec4dfc,202775,-1,44,2018-10-25 20:35:52.646000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_541013,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy Caucasian male or females with no clinically significant abnormality identified by the physician by evaluation of medical history, physical examination, clinical laboratory tests or 12-lead ECG. - Subjects",ct_inc_541013,AACT,30,NCT00688272,Caucasian,white
5bd229355d72d27341ec4dfc,128775,-1,57,2018-10-25 20:36:05.146000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_473564,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy Caucasian and Japanese male individuals.,ct_inc_473564,AACT,30,NCT01575587,Caucasian,white
5bd229f15d72d27782ec4dfc,48625,-1,54,2018-10-25 20:39:13.807000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_428019,Clinical Trial Inclusion Criteria,"Inclusion Criteria: Japanese or Caucasian healthy male subjects according to the following criteria: Based upon a complete medical history, including the physical examination, vital signs (blood pressure, pulse rate and body temperature), 12-lead electrocardiogram, clinical laboratory tests - No finding of clinical relevance -",ct_inc_428019,AACT,32,NCT02171468,Caucasian,white
5bd22a195d72d2784cec4dfc,52875,-1,156,2018-10-25 20:39:53.885000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_430415,Clinical Trial Inclusion Criteria,Inclusion Criteria: MetS is defined as having three or more (>= 3) of the following conditions: - Central obesity - Waist circumference >= 90 cm (Asian male); 80 cm (Asian female) - High blood pressure - Systolic blood pressure/diastolic blood pressure >= 130/85 mmHg or use of hypertension drug - Elevated blood glucose - Fasting blood glucose >= 100 mg/dL or use of hyperglycemia drug - Elevated blood triglyceride - Blood triglyceride >= 150 mg/dL - Reduced HDL-cholesterol - HDL-C <= 40 mg/dL (male); <= 50 mg/dL (female),ct_inc_430415,AACT,146,NCT02140203,Asian,asian
5bd22a1a5d72d27848ec4dfc,136075,-1,44,2018-10-25 20:39:54.553000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_480810,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy Caucasian male or post-menopausal/surgical sterile females, aged 18 to 45 years inclusive at screening -",ct_inc_480810,AACT,30,NCT01480739,Caucasian,white
5bd22a1d5d72d27862ec4dfc,193025,-1,48,2018-10-25 20:39:57.028000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_495361,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy - Female caucasians - Age 18 - 45 years old - BMI 18.5 - 26 kg/m2,ct_inc_495361,AACT,32,NCT01289756,caucasian,white
5bd22af25d72d27cf0ec4dfc,240625,-1,36,2018-10-25 20:43:30.472000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_557505,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male Caucasian subjects, aged 18-55 years - BMI between 18 and 30 kg/m2 inclusive, with a lower limit of body weight of 50 kg - Subjects must be in good health as determined by medical history, physical examination, 12-lead electrocardiogram, vital signs, and clinical laboratory parameters.",ct_inc_557505,AACT,22,NCT00469404,Caucasian,white
5bd22b765d72d27fdcec4dfc,67625,-1,132,2018-10-25 20:45:42.977000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_378534,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male subjects - Age: 18 to 45 years (inclusive) - Body mass index (BMI) : 18 and 30 kg/m - Race: White,ct_inc_378534,AACT,121,NCT02817100,White,white
5bd22c155d72d204a8ec4dfc,86100,-1,121,2018-10-25 20:48:21.182000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_317950,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Written informed consent has been signed prior to or at Screening Visit - Caucasian male and female patients - Age 18 years -,ct_inc_317950,AACT,96,NCT03606122,Caucasian,white
5bd22d185d72d20a6bec4dfc,239650,-1,46,2018-10-25 20:52:40.890000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_554033,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male or female subjects aged 40-75 years inclusive.,ct_inc_554033,AACT,22,NCT00515502,Caucasian,white
5bd22d285d72d20accec4dfc,158050,-1,26,2018-10-25 20:52:56.405000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_432967,Clinical Trial Inclusion Criteria,- Male or Female Caucasian patients >,ct_inc_432967,AACT,2,NCT02106845,Caucasian,white
5bd22d635d72d20c24ec4dfc,240725,-1,42,2018-10-25 20:53:55.063000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_557409,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Asian patients 50 years of age or greater.,ct_inc_557409,AACT,22,NCT00470678,Asian,asian
5bd22e915d72d212cdec4dfc,107450,-1,89,2018-10-25 20:58:57.785000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_578454,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - cases: pregnant woman, evolutive pregnancy, preeclampsia, caucasian, consenting to the study",ct_inc_578454,AACT,38,NCT00190177,caucasian,white
5bd22ec95d72d2140cec4dfc,51275,-1,60,2018-10-25 20:59:53.056000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_432031,Clinical Trial Inclusion Criteria,"Or, healthy non-Hispanic Caucasian subjects, male and female, 18 to 45 years of age, inclusive, and in good health as determined by past medical history, physical examination, vital signs, electrocardiogram, and laboratory tests at screening (only for SCR site).",ct_inc_432031,AACT,25,NCT02119091,Caucasian,white
5bd22f9d5d72d218c0ec4dfc,108400,-1,44,2018-10-25 21:03:25.967000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_581410,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male Caucasian subject aged between 18 and 55 years (both inclusive).,ct_inc_581410,AACT,30,NCT00150761,Caucasian,white
5bd2304d5d72d21c84ec4dfc,176500,-1,147,2018-10-25 21:06:21.446000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_527854,Clinical Trial Inclusion Criteria,"Mild to moderate depression (ICD-10 F32.0, F32.1) with atypical features according to DSM-IV, lasting at least 3 months - Female and male Caucasians aged 18 to 70 years -",ct_inc_527854,AACT,122,NCT00861978,Caucasian,white
5bd230f85d72d22062ec4dfc,113875,-1,25,2018-10-25 21:09:12.914000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_567110,Clinical Trial Inclusion Criteria,"Male and female Caucasians, age 4 years old and older.",ct_inc_567110,AACT,0,NCT00341770,Caucasian,white
5bd2316b5d72d222ebec4dfc,61875,-1,89,2018-10-25 21:11:07.451000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_368357,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Waist circumference100cm OR HbA1c6.0% - South Asian, Male or Female, and age 40-70 years",ct_inc_368357,AACT,68,NCT02949739,Asian,asian
5bd2317f5d72d2234fec4dfc,115575,-1,70,2018-10-25 21:11:27.034000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_569369,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy male volunteer , citizen of the European Community.",ct_inc_569369,AACT,30,NCT00311571,European,white
5bd232e95d72d22b5fec4dfc,58825,-1,90,2018-10-25 21:17:29.238000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_379182,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Self-Identified as an African American or a Hispanic American female - Speak English and/or Spanish - Mentally and Physically capable of completing the consenting process,ct_inc_379182,AACT,44,NCT02808598,African American,black
5bd2343c5d72d232ebec4dfc,116450,-1,24,2018-10-25 21:23:08.479000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_565236,Clinical Trial Inclusion Criteria,Female patients of Asian and darker skin type greater than or equal to 18 years of age.,ct_inc_565236,AACT,0,NCT00366964,Asian,asian
5bd2345f5d72d233c3ec4dfc,92675,-1,36,2018-10-25 21:23:43.302000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_350653,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - male Caucasian subject - age between 18 and 55 years (inclusive) - physically and mentally healthy as judged by means of medical and standard laboratory examinations - non-smokers or ex-smokers (stopped at least 6 months ago) with a smoking history of 5 pack-year equivalents (1 pack-year equivalent is equal to smoking 1 pack per day for 1 year ) and non-users of other nicotine containing products, confirmed by urine cotinine test - BMI within the range (including the borders) of 18.5 to 30.0 kg/m2 and body weight not more than 105.0 kg - Informed consent given in written form according to Section 5.4 of the protocol.",ct_inc_350653,AACT,22,NCT03180242,Caucasian,white
5bd234cb5d72d23650ec4dfc,237900,-1,39,2018-10-25 21:25:31.578000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_556250,Clinical Trial Inclusion Criteria,7 Infant born from parents of Caucasian race Exclusive breast feeding or formula feeding within 15 days from birth.,ct_inc_556250,AACT,2,NCT00486148,Caucasian,white
5bd2352e5d72d238a5ec4dfc,325,-1,22,2018-10-25 21:27:10.614000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_391335,Clinical Trial Inclusion Criteria,- Adult Caucasian male aged 20 and 50 years.,ct_inc_391335,AACT,8,NCT02650076,Caucasian,white
5bd235905d72d23ac1ec4dfc,248250,-1,31,2018-10-25 21:28:48.652000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_572564,Clinical Trial Inclusion Criteria,African American male or female patients 18 years of age Documented HIV-infected Currently on Kaletra soft-gel capsules for >2 weeks Competent and willingness to sign and date a written informed consent,ct_inc_572564,AACT,0,NCT00268827,African American,black
5bd235a45d72d23b48ec4dfc,181150,-1,99,2018-10-25 21:29:08.892000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_518610,Clinical Trial Inclusion Criteria,"- Normal physical examination, laboratory values, blood pressure and pulse - Healthy male caucasian subjects",ct_inc_518610,AACT,85,NCT00984477,caucasian,white
5bd235e45d72d23ca5ec4dfc,200900,-1,93,2018-10-25 21:30:12.483000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_533025,Clinical Trial Inclusion Criteria,"Is willing and likely to be able to comply with the trial procedures Is female/male non-black adult 18 years and 55 years of age Is healthy according to a medical examination, medical history and laboratory investigations at inclusion",ct_inc_533025,AACT,79,NCT00793702,black,black
5bd2362b5d72d23e26ec4dfc,81125,-1,14,2018-10-25 21:31:23.225000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_335204,Clinical Trial Inclusion Criteria,"Male Caucasian subjects, aged 30 to 55 years (inclusive) at Screening.",ct_inc_335204,AACT,0,NCT03381404,Caucasian,white
5bd236525d72d23ef7ec4dfc,48850,-1,119,2018-10-25 21:32:02.307000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_427860,Clinical Trial Inclusion Criteria,"The subject must be at least 18 years of age and no more than 39 years of age (inclusive) Subjects must be Asian female Subjects must be able to read Chinese Subjects' monthly household income must be above HKD$ 10,000 Subjects must be habitual soft contact lens wearer or habitual limbal lens wearer or have a history of previous habitual lens wear.",ct_inc_427860,AACT,107,NCT02173535,Asian,asian
5bd236da5d72d2421eec4dfc,161350,-1,46,2018-10-25 21:34:18.915000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_445060,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Caucasians aged between 18 and 60 years - Patients with mild to moderate AD (Atopic Dermatitis) presenting a scoring AD (SCORAD) rating below 50 - Skin type I - IV according to Fitzpatrick - Acute AD symptoms on each assessment areas (local SCORAD 3 and </= 12) at Baseline - Acute symptom of pruritus at Baseline,ct_inc_445060,AACT,22,NCT01948869,Caucasian,white
5bd236ef5d72d2428bec4dfc,11150,-1,37,2018-10-25 21:34:39.734000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_414459,Clinical Trial Inclusion Criteria,"- Caucasian, defined as an individual having four grandparents who are all descendents of the original peoples of Europe.",ct_inc_414459,AACT,2,NCT02348372,Caucasian,white
5bd237715d72d2457bec4dfc,200225,-1,63,2018-10-25 21:36:49.649000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_529044,Clinical Trial Inclusion Criteria,"18-55 years of age, Caucasian, Finnish speaking, male or female subjects.",ct_inc_529044,AACT,20,NCT00846235,Caucasian,white
5bd237805d72d245d3ec4dfc,104425,-1,44,2018-10-25 21:37:04.977000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_363393,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy Caucasian male subjects, 40-55 years of age.",ct_inc_363393,AACT,30,NCT03014375,Caucasian,white
5bd238705d72d24b3dec4dfc,154950,-1,37,2018-10-25 21:41:04.350000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_448783,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian, male healthy subjects of 18 to 45 years of age (inclusive).",ct_inc_448783,AACT,22,NCT01900184,Caucasian,white
5bd238705d72d24b3dec4dfd,154950,-1,37,2018-10-25 21:41:04.393000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_448784,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian, male healthy subjects of 18 to 45 years of age.",ct_inc_448784,AACT,22,NCT01900171,Caucasian,white
5bd239185d72d24ef3ec4dfc,41600,-1,86,2018-10-25 21:43:52.157000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_402760,Clinical Trial Inclusion Criteria,"Japanese male: 50.0 kg, <80.0 kg - Japanese female: 40.0 kg, <70.0 kg - Caucasian male: 50.0 kg, <100.0 kg - BMI (at screening) -",ct_inc_402760,AACT,72,NCT02500953,Caucasian,white
5bd23aab5d72d257d4ec4dfc,167825,-1,22,2018-10-25 21:50:35.593000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_463703,Clinical Trial Inclusion Criteria,"Healthy Caucasian male subjects, aged 18-45 years inclusive, will be entered into this study.",ct_inc_463703,AACT,8,NCT01705275,Caucasian,white
5bd23bd05d72d25e60ec4dfc,211400,-1,41,2018-10-25 21:55:28.357000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_474304,Clinical Trial Inclusion Criteria,All subjects: - Male and female Caucasian subjects 18 to 70 years of age -,ct_inc_474304,AACT,16,NCT01565902,Caucasian,white
5bd23c885d72d26296ec4dfc,195875,-1,33,2018-10-25 21:58:32.076000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_498903,Clinical Trial Inclusion Criteria,"- The subject is a Caucasian male (Caucasian is defined as having origins in the original peoples of Europe, the Middle East, Western Russia, Afghanistan, or the white racial groups of Africa).",ct_inc_498903,AACT,19,NCT01243502,Caucasian,white
5bd23cb35d72d26396ec4dfc,39000,-1,17,2018-10-25 21:59:15.450000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_406474,Clinical Trial Inclusion Criteria,- Race: Caucasian,ct_inc_406474,AACT,2,NCT02452515,Caucasian,white
5bd23ccc5d72d26429ec4dfc,184325,-1,42,2018-10-25 21:59:40.822000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_520607,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - healthy, white, male volunteers between 18 and 55 years of age",ct_inc_520607,AACT,31,NCT00957944,white,white
5bd23d5c5d72d26771ec4dfc,240675,-1,55,2018-10-25 22:02:04.078000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_557366,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy female and male Caucasians - Age between 30 and 70 years at Day 01 of the study - Body Mass Index,ct_inc_557366,AACT,30,NCT00471263,Caucasian,white
5bd23d675d72d267d4ec4dfc,39475,-1,82,2018-10-25 22:02:15.026000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_405559,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Type 2 diabetes mellitus - Non-white, post menopausal female - Have access to Community Health Center",ct_inc_405559,AACT,53,NCT02464462,white,white
5bd23db95d72d269b4ec4dfc,32050,-1,24,2018-10-25 22:03:37.346000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_397313,Clinical Trial Inclusion Criteria,Caucasian Male or female between the ages of 65 and 79 years old Three or more Fried Frailty Criteria (as diagnosed by investigator),ct_inc_397313,AACT,0,NCT02572063,Caucasian,white
5bd23dc75d72d26a10ec4dfc,203275,-1,65,2018-10-25 22:03:51.885000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_540800,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Identify as a black / African American male - Report sex with at least 2 people in past 3 months/ 1 being male - Willingness to take HIV test or provide documentation if HIV+ - Willingness to identify and recruit friend/relative to study,ct_inc_540800,AACT,44,NCT00691041,African American,black
5bd23e145d72d26bcfec4dfc,189300,-1,48,2018-10-25 22:05:08.451000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_503684,Clinical Trial Inclusion Criteria,The subject must be a light eye Caucasian female habitual soft contact lens wearer.,ct_inc_503684,AACT,32,NCT01180777,Caucasian,white
5bd23e3e5d72d26ce6ec4dfc,143775,-1,55,2018-10-25 22:05:50.692000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_499157,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy Caucasian male and female volunteers aged 18 to 55 years inclusive with suitable veins for venepuncture -,ct_inc_499157,AACT,30,NCT01240148,Caucasian,white
5bd23eae5d72d26f68ec4dfc,129100,-1,67,2018-10-25 22:07:42.121000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_473912,Clinical Trial Inclusion Criteria,Inclusion Criteria: Adolescents: - Male and female African American and Latino/a youth ages 13 -17 years old.,ct_inc_473912,AACT,35,NCT01571011,African American,black
5bd23ec95d72d27002ec4dfc,62675,-1,43,2018-10-25 22:08:09.789000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_366045,Clinical Trial Inclusion Criteria,Parent-reported child race African American/Black.,ct_inc_366045,AACT,22,NCT02979860,African American,black
5bd23ed25d72d27035ec4dfc,232025,-1,81,2018-10-25 22:08:18.627000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_576838,Clinical Trial Inclusion Criteria,"Inclusion Criteria: Male and female, English or Spanish speaking African American and/or Hispanic patients with uncontrolled hypertension who have been seen in either the Cardiology clinic, Internal Medicine Associates (IMA) or Geriatric clinic at least twice in a given year at least 18 years of age.",ct_inc_576838,AACT,20,NCT00211666,African American,black
5bd23f695d72d273a6ec4dfc,220675,-1,115,2018-10-25 22:10:49.055000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_551707,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Signed informed consent - Healthy, based on medical examination at inclusion - Male Caucasian subjects, aged between 18 and 40 years - Willing and likely to be able to comply with the trial procedures",ct_inc_551707,AACT,101,NCT00546273,Caucasian,white
5bd23ff75d72d276f1ec4dfc,203725,-1,64,2018-10-25 22:13:11.695000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_535154,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male and female English-speaking Caucasian patients >4 years of age with a history of stone formation before age 20 years, their family members, and sex- and age-matched pediatric normal volunteers will be included regardless of current age, gender, race or ethnicity.",ct_inc_535154,AACT,22,NCT00765531,Caucasian,white
5bd241785d72d27f81ec4dfc,188300,-1,107,2018-10-25 22:19:36.467000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_493017,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Informed consent obtained prior to any screening procedure - Caucasian male or female patient -,ct_inc_493017,AACT,83,NCT01320579,Caucasian,white
5bd2418c5d72d20137ec4dfc,22200,-1,68,2018-10-25 22:19:56.937000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_368032,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Must be male and self-reported American Indian; ages 18-65,",ct_inc_368032,AACT,30,NCT02953977,American Indian,american indian
5bd243335d72d27174ec4dfc,50600,-1,44,2018-10-25 22:26:59.138000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_423551,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male Caucasian subjects as determined by results of screening - Written informed consent in accordance with GCP and local legislation given - Age >= 18 and <= 65 years - Broca >= - 20% and <= + 30% - LDL-cholesterol level >= 3.3 mmol/L at pre-screening and at the two screening visits,ct_inc_423551,AACT,30,NCT02229773,Caucasian,white
5bd243c25d72d20e8eec4dfc,78000,-1,73,2018-10-25 22:29:22.369000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_327423,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - written informed consent - Caucasian male or female subjects aged between 18 and 55years - Physically and mentally healthy - BMI between 19 and 29 kg/m2, and body weight 90 kg - Non-smoker -",ct_inc_327423,AACT,49,NCT03482817,Caucasian,white
5bd244ca5d72d2148eec4dfc,141775,-1,58,2018-10-25 22:33:46.893000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_514935,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American or Caucasian Female - Age between 55 - 79 years,ct_inc_514935,AACT,22,NCT01032733,African American,black
5bd244e95d72d2152fec4dfc,148500,-1,48,2018-10-25 22:34:17.303000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_509412,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian or Japanese male - Japanese participant born in Japan of Japanese parents and maternal and paternal grandparents must not have lived outside of Japan for more than 5 years, and lifestyles including diet, must not have changed significantly since relocating from Japan - Caucasian male or postmenopausal/surgically sterile Caucasian female - Caucasian participant born of Caucasian parents and maternal and paternal grandparents must continue their usual lifestyle and diet - Weight = 50 kilograms and Body Mass Index (BMI) between 18.5 and 29.9 kg/m2 (inclusive) -",ct_inc_509412,AACT,22,NCT01105780,Caucasian,white
5bd245215d72d2169aec4dfc,224825,-1,22,2018-10-25 22:35:13.546000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_433563,Clinical Trial Inclusion Criteria,Healthy Caucasian male subjects aged between 18 and 45 years (inclusive) at screening.,ct_inc_433563,AACT,8,NCT02099071,Caucasian,white
5bd246995d72d21f5aec4dfc,135300,-1,82,2018-10-25 22:41:29.070000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_483952,Clinical Trial Inclusion Criteria,Inclusion Criteria: - 15-29 years of age - Identifying as an African American Male - Males must be presenting themselves for STD testing - Males must report recently (past 3 months) engaging in penile-anal sex with other males as a top (meaning the insertive partner),ct_inc_483952,AACT,61,NCT01439503,African American,black
5bd2469b5d72d21f70ec4dfc,168275,-1,66,2018-10-25 22:41:31.486000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_462883,Clinical Trial Inclusion Criteria,Inclusion Criteria: - 18-70 year-old Asian-American male or female patients with HBeAg+ or HBeAg-CHB -,ct_inc_462883,AACT,37,NCT01715987,Asian,asian
5bd246cb5d72d220a4ec4dfc,62900,-1,127,2018-10-25 22:42:19.884000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_366385,Clinical Trial Inclusion Criteria,Healthy female postmenopausal subjects - Age: 45 to 65 years (inclusive) - Body mass index (BMI) : 20 and 32 kg/m - Race: White,ct_inc_366385,AACT,116,NCT02975440,White,white
5bd246f85d72d221a1ec4dfc,188350,-1,37,2018-10-25 22:43:04.509000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_493069,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male, Caucasian subjects aged between 18-40 years (inclusive) - Healthy subjects as determined by medical history, physical examination - Body weight between 70 - 100 kg and BMI between 19 and 29 kg/m2, extremes incl - ECG recording based on a 12-lead ECG which is normal (PR < 210 ms, QRS <110 ms, QTC 380 -430 ms) or contains only slight deviations - Normal vital signs (after 5 minutes resting), blood pressure values (systolic > or equal to 100 and < or equal to 140 mmHg, diastolic > or equal to 50 and < or equal to 90 mmHg), heart rate between 45 and 90 beats per minute (bpm), body temperature",ct_inc_493069,AACT,22,NCT01319903,Caucasian,white
5bd2471d5d72d22263ec4dfc,160100,-1,51,2018-10-25 22:43:41.611000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_444768,Clinical Trial Inclusion Criteria,For Non-Caucasians: - Non-Caucasian male and female adult participants (greater than or equal to 18 years of age) with an initial diagnosis of suspected PD or ET who underwent DaTscan SPECT imaging to assist with the participant's final clinical diagnosis of PD or ET.,ct_inc_444768,AACT,26,NCT01952678,Caucasian,white
5bd2471d5d72d22263ec4dfd,160100,-1,16,2018-10-25 22:43:41.815000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_444775,Clinical Trial Inclusion Criteria,Caucasian Female 2.,ct_inc_444775,AACT,0,NCT01952587,Caucasian,white
5bd247d75d72d2268bec4dfc,21725,-1,32,2018-10-25 22:46:47.431000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_356666,Clinical Trial Inclusion Criteria,American Indian ethnicity Female 3.,ct_inc_356666,AACT,0,NCT03101943,American Indian,american indian
5bd249575d72d22f23ec4dfc,110000,-1,23,2018-10-25 22:53:11.466000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_566168,Clinical Trial Inclusion Criteria,- African American male -,ct_inc_566168,AACT,2,NCT00354497,African American,black
5bd249735d72d22fb9ec4dfc,157150,-1,67,2018-10-25 22:53:39.616000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_443233,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male and Female African American or Caucasian subjects older than 18 years of age.,ct_inc_443233,AACT,22,NCT01972737,Caucasian,white
5bd249b05d72d23149ec4dfc,209525,-1,36,2018-10-25 22:54:40.107000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_490850,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male Caucasian Adults between 30 and 65 years old Sedentary criteria based on the determination of fasting glucose (WHO 1999): - normal if fasting plasma glucose (FPG),ct_inc_490850,AACT,22,NCT01349166,Caucasian,white
5bd249b45d72d2315bec4dfc,247800,-1,95,2018-10-25 22:54:44.685000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_583647,Clinical Trial Inclusion Criteria,(child must be randomized on or before their 6-month birthday) - Male or female Native American - General state of good health - Written informed consent obtained from the patient's parent(s) or legal guardian,ct_inc_583647,AACT,65,NCT00121108,Native American,native american
5bd24ae55d72d2389eec4dfc,6700,-1,35,2018-10-25 22:59:49.710000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_415026,Clinical Trial Inclusion Criteria,"East Asian subjects, male or female, and age between 18 (or legal adult age) and 70 years, inclusive, at Baseline/Day 3.",ct_inc_415026,AACT,5,NCT02340962,Asian,asian
5bd24aed5d72d238a2ec4dfc,219550,-1,115,2018-10-25 22:59:57.517000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_545146,Clinical Trial Inclusion Criteria,"Healthy volunteers and patients with type 2 diabetes - Non-smoking, Caucasian and African American, male and female (postmenopausal, surgically sterile or using double-barrier method of contraception) subjects between 30 and 65 years of age (inclusive) - Type 2 diabetics on metformin and/or sufonylurea",ct_inc_545146,AACT,68,NCT00633997,Caucasian,white
5bd24b0e5d72d23994ec4dfc,117925,-1,54,2018-10-25 23:00:30.923000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_561248,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male or Female, African American (self-reported), 12 years of age - Moderate to severe asthma requiring treatment with an inhaled corticosteroid - Diagnosis of asthma for at least 6 months",ct_inc_561248,AACT,22,NCT00419952,African American,black
5bd24bdc5d72d23e85ec4dfc,137825,-1,59,2018-10-25 23:03:56.894000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_479710,Clinical Trial Inclusion Criteria,Healthy adult male Japanese or healthy adult Caucasian male.,ct_inc_479710,AACT,45,NCT01495065,Caucasian,white
5bd24cf35d72d244c0ec4dfc,137725,-1,12,2018-10-25 23:08:35.829000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_479532,Clinical Trial Inclusion Criteria,Female Black/African 3.,ct_inc_479532,AACT,0,NCT01497405,Black,black
5bd24cf45d72d244c0ec4dfd,137725,-1,42,2018-10-25 23:08:36.345000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_479541,Clinical Trial Inclusion Criteria,Healthy male and female Caucasian or Black subjects between 18 and 55 years with a body mass index of 18-28 kg/m2 and a minimum weight of 50 kg.,ct_inc_479541,AACT,8,NCT01497288,Black,black
5bd24d995d72d24867ec4dfc,222925,-1,25,2018-10-25 23:11:21.444000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_440492,Clinical Trial Inclusion Criteria,- Individual of Caucasian origin - Individual having signed the form of specific consent for the study individual .,ct_inc_440492,AACT,2,NCT02008552,Caucasian,white
5bd24eaf5d72d24e8cec4dfc,166500,-1,56,2018-10-25 23:15:59.512000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_471561,Clinical Trial Inclusion Criteria,family identifies the child as black or African American; 3.,ct_inc_471561,AACT,22,NCT01601847,African American,black
5bd24f3a5d72d2518eec4dfc,36925,-1,34,2018-10-25 23:18:18.335000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_408549,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Asian Female patients at least 18 years of age - Clinical or surgical diagnosis of endometriosis (depending on local approved indication) :,ct_inc_408549,AACT,22,NCT02425462,Asian,asian
5bd24f4b5d72d251f4ec4dfc,207375,-1,79,2018-10-25 23:18:35.638000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_486774,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Self-identification as an African-American or Black woman - Age 35-65 years - Body mass index,ct_inc_486774,AACT,68,NCT01402557,Black,black
5bd24fb95d72d25497ec4dfc,220875,-1,48,2018-10-25 23:20:25.320000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_412236,Clinical Trial Inclusion Criteria,- Caucasian subjects as defined as an individual having four grandparents who are all descendants of the original peoples of Europe.,ct_inc_412236,AACT,2,NCT02377414,Caucasian,white
5bd24ff15d72d255c4ec4dfc,123850,-1,74,2018-10-25 23:21:21.966000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_588630,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Adult, male or female, African-American or Caucasian, age 18 or older.",ct_inc_588630,AACT,29,NCT00071916,Caucasian,white
5bd2502c5d72d256ffec4dfc,130750,-1,17,2018-10-25 23:22:20.515000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_450404,Clinical Trial Inclusion Criteria,Male of Caucasian ethnic origin.,ct_inc_450404,AACT,0,NCT01879020,Caucasian,white
5bd250c05d72d25a44ec4dfc,3325,-1,236,2018-10-25 23:24:48.409000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_419406,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Availability of volunteer for the entire study period and willingness to adhere to protocol requirements as evidenced by the informed consent form (ICF) duly read, signed and dated by the volunteer - Non-black male aged of at least 18 years but not older than 45 years with a body mass index (BMI) greater than or equal to 19 and below 30 kg/m2 - Clinical laboratory values within the laboratory's stated normal range",ct_inc_419406,AACT,226,NCT02283827,black,black
5bd250db5d72d25af7ec4dfc,118650,-1,36,2018-10-25 23:25:15.318000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_557532,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male Caucasian subjects, aged 18-55 years - BMI between 18 and 30 kg/m2 inclusive, with a lower limit of body weight of 50 kg - Subjects must be in good health as determined by medical history, physical examination, 12-lead electrocardiogram, vital signs, and clinical laboratory parameters.",ct_inc_557532,AACT,22,NCT00469053,Caucasian,white
5bd251d45d72d26073ec4dfc,126725,-1,40,2018-10-25 23:29:24.378000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_594687,Clinical Trial Inclusion Criteria,They were almost entirely white and male (>90%).,ct_inc_594687,AACT,26,NCT00018473,white,white
5bd252985d72d26497ec4dfc,200625,-1,58,2018-10-25 23:32:40.127000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_529981,Clinical Trial Inclusion Criteria,- Subjects will be Caucasian males or females of non-child bearing potential between 18 and 65 years of age - Subjects will have given their written informed consent to participate in the study and to abide by the study restrictions,ct_inc_529981,AACT,19,NCT00833872,Caucasian,white
5bd252cd5d72d265efec4dfc,158850,-1,16,2018-10-25 23:33:33.032000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_454233,Clinical Trial Inclusion Criteria,Caucasian female - Within at least 7 years post-menopause,ct_inc_454233,AACT,0,NCT01828944,Caucasian,white
5bd253635d72d2696fec4dfc,221275,-1,44,2018-10-25 23:36:03.615000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_411121,Clinical Trial Inclusion Criteria,Inclusion Criteria: Male or female Caucasian in good health between the age of 50 and 65 years.,ct_inc_411121,AACT,20,NCT02391935,Caucasian,white
5bd256405d72d27a2eec4dfc,64350,-1,54,2018-10-25 23:48:16.455000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_372303,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American male and female subjects participating in COPDGene study,ct_inc_372303,AACT,22,NCT02898272,African American,black
5bd256775d72d27b4cec4dfc,129200,-1,20,2018-10-25 23:49:11.306000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_473383,Clinical Trial Inclusion Criteria,Adult male Caucasian patients aged 18-45 years (both included).,ct_inc_473383,AACT,6,NCT01577953,Caucasian,white
5bd256855d72d27b9cec4dfc,143525,-1,39,2018-10-25 23:49:25.787000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_455419,Clinical Trial Inclusion Criteria,"The subject is a healthy Caucasian male and has a BMI of 18.0 to 32.0 kg/m2, inclusive",ct_inc_455419,AACT,25,NCT01813448,Caucasian,white
5bd256b95d72d27cd0ec4dfc,176925,-1,45,2018-10-25 23:50:17.805000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_528586,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American female - Delivery of a VLBW,ct_inc_528586,AACT,22,NCT00852319,African American,black
5bd256d05d72d27d66ec4dfc,29150,-1,14,2018-10-25 23:50:40.796000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_387155,Clinical Trial Inclusion Criteria,Caucasian male 19-55 years of age.,ct_inc_387155,AACT,0,NCT02704702,Caucasian,white
5bd258765d72d207c2ec4dfc,85400,-1,53,2018-10-25 23:57:42.716000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_317022,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female African Americans 30 years of age or older - Subjects who have completed or are scheduled to undergo the neurological evaluation procedures described below.,ct_inc_317022,AACT,22,NCT03618186,African American,black
5bd258765d72d207c2ec4dfd,85400,-1,48,2018-10-25 23:57:42.806000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_317024,Clinical Trial Inclusion Criteria,"For Part 3, participant must be a Caucasian male (defined as white and all of his parents and grandparents are white as determined by participant's verbal report) 20 to 65 years of age, inclusive, at the time of informed consent for screening - Participant must agree to use an adequate contraception method as deemed appropriate by the investigator; to always use a condom during sexual intercourse (even in case of prior vasectomy), or to remain abstinent, and not to donate sperm during the study and for 90 days after study drug administration.",ct_inc_317024,AACT,34,NCT03618160,Caucasian,white
5bd2587f5d72d207eaec4dfc,53925,-1,55,2018-10-25 23:57:51.567000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_425091,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male and female Caucasian subjects as determined by results of screening - Written informed consent in accordance with Good Clinical Practice and local legislation given - Age 18 and 50 years - Broca - 20 % and + 20 % - for first part of study: extensive metabolizers of CYP2D6 and/or spartein type; for second part of study: poor metabolizers of CYP2D6 and/or spartein,ct_inc_425091,AACT,30,NCT02209688,Caucasian,white
5bd2587f5d72d207eaec4dfd,53925,-1,55,2018-10-25 23:57:51.953000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_425094,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male and female Caucasian subjects as determined by results of screening - Age 18 and 50 years - Broca - 20 % and + 20 % - Written informed consent in accordance with Good Clinical Practice and local legislation given,ct_inc_425094,AACT,30,NCT02209649,Caucasian,white
5bd2599e5d72d20eb5ec4dfc,187750,-1,55,2018-10-26 00:02:38.741000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_486305,Clinical Trial Inclusion Criteria,Adult male Age range 30-65 years at screening Caucasian or Indian ethnicity,ct_inc_486305,AACT,6,NCT01408667,Caucasian,white
5bd25aac5d72d214e5ec4dfc,182300,-1,54,2018-10-26 00:07:08.868000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_527006,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy male or female Caucasian subjects - Aged between 18 and 70 years, inclusive, at screening - BMI between 20.0 and 29.9 kg/m, inclusive.",ct_inc_527006,AACT,30,NCT00873197,Caucasian,white
5bd25afa5d72d216afec4dfc,131375,-1,107,2018-10-26 00:08:26.846000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_481147,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Informed consent obtained prior to any screening procedure - Caucasian male or female subject - Age 18-65 y - Weight at least 45 kg - Corrected visual acuity > 20/25 in both eyes - Intraocular pressure < 21 mmHg, with a difference between eyes of < 4 mmHg - Ability to tolerate and self-administer vehicle eye drops - Normal slit lamp examination and dilated fundoscopic examination - Normal clinical laboratory profiles, defined as complete blood count, serum chemistry, and urinalysis values within the normal range - Willingness to abstain from concomitant use of ocular or systemic medication (excluding oral contraceptives, ibuprofen, paracetamol, calcium preparations and vitamins) from 2 weeks prior to the start of study dosing until study completion - Willingness to comply with study-related procedures - Negative urine pregnancy test (premenopausal female subject) at screening and use of adequate contraceptive measures throughout the study and 30 days after the last study medication dose - A premenopausal female subject should be either surgically sterile or using a reliable contraception method: intrauterine device; oral combination pill or hormonal contraception patch; or two of the following: intra-vaginal hormonal ring, oral contraceptive containing progestin only, spermicidal foam, condom, sterilization of male sexual partner (surgical vasectomy) - Subject with no current heterosexual relationship may be included according to the judgment of the Investigator -",ct_inc_481147,AACT,83,NCT01476332,Caucasian,white
5bd25b2d5d72d217b4ec4dfc,69525,-1,44,2018-10-26 00:09:17.415000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_434117,Clinical Trial Inclusion Criteria,Child is an American Indian or Alaska Native living on or near the Tribe's reservation.,ct_inc_434117,AACT,0,NCT02091804,Alaska Native,alaska native
5bd25bdc5d72d21b87ec4dfc,35650,-1,31,2018-10-26 00:12:12.179000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_389167,Clinical Trial Inclusion Criteria,"Subject must be male, Caucasian, between 18 and 55 years of age (inclusive) at the time of the screening.",ct_inc_389167,AACT,16,NCT02678416,Caucasian,white
5bd25be25d72d21ba4ec4dfc,96325,-1,55,2018-10-26 00:12:18.383000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_344094,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Self-identify as female and black or AA - Age 18-70 - Sub-optimally controlled persistent asthma based on Asthma Control Test (ACT <20) - Wiling to enroll and provide written-informed consent - Willing to be randomly assigned to treatment or control group,ct_inc_344094,AACT,39,NCT03265665,black,black
5bd25ce55d72d2213eec4dfc,152250,-1,47,2018-10-26 00:16:37.471000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_507351,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male and female Caucasian outpatients aged > 40 years.,ct_inc_507351,AACT,22,NCT01132768,Caucasian,white
5bd25dc95d72d22650ec4dfc,114250,-1,16,2018-10-26 00:20:25.263000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_567971,Clinical Trial Inclusion Criteria,Caucasian female Community dwelling women,ct_inc_567971,AACT,0,NCT00330096,Caucasian,white
5bd25f355d72d22ea3ec4dfc,17000,-1,64,2018-10-26 00:26:29.018000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_376150,Clinical Trial Inclusion Criteria,"The population consists of all female English-speaking Caucasian patients of the Department for plastic and aesthetic surgery of Ocean Clinic Marbella, Spain, between 40 and 80 years seeking for elective facial rejuvenation with the PAVE-lift technique (peeling assisted volume enhancing Facelift) who give formal written informed consent to take part in the study.",ct_inc_376150,AACT,31,NCT02848209,Caucasian,white
5bd25f425d72d22ef3ec4dfc,190325,-1,73,2018-10-26 00:26:42.943000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_500464,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian or Asian healthy subjects, Male or female, aged between 18 and 50 years (inclusive) - Body Mass Index (BMI) between 19.0 kg/m2 and 27.0 kg",ct_inc_500464,AACT,22,NCT01222949,Caucasian,white
5bd25f9a5d72d230edec4dfc,89050,-1,22,2018-10-26 00:28:10.080000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_322535,Clinical Trial Inclusion Criteria,- Individual Caucasian subjects should be selected to match body weight ( 20%) and height ( 15%) of corresponding Japanese subjects.,ct_inc_322535,AACT,2,NCT03546465,Caucasian,white
5bd260875d72d23670ec4dfc,60225,-1,28,2018-10-26 00:32:07.742000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_369306,Clinical Trial Inclusion Criteria,"Self-reported race Caucasian, African American, or African - Serum total 25(OH)D 10-50 ng/mL - Estimated",ct_inc_369306,AACT,14,NCT02937350,Caucasian,white
5bd260d45d72d2381dec4dfc,52450,-1,57,2018-10-26 00:33:24.541000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_428774,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male Japanese and Caucasian subjects - Age between 20 and 55 years (both inclusive),ct_inc_428774,AACT,30,NCT02161588,Caucasian,white
5bd261fb5d72d23ea9ec4dfc,195850,-1,36,2018-10-26 00:38:19.284000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_498874,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male volunteers - Age > 18 years and < 70 years - Body mass index,ct_inc_498874,AACT,22,NCT01243879,Caucasian,white
5bd2620a5d72d23f02ec4dfc,62500,-1,63,2018-10-26 00:38:34.261000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_366901,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy, adult, Caucasian, male or female 18 years of age at screening - Body mass index 18.0 and 32.0 kg/m2 at screening -",ct_inc_366901,AACT,38,NCT02968719,Caucasian,white
5bd262ad5d72d242a8ec4dfc,28600,-1,51,2018-10-26 00:41:17.427000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_387423,Clinical Trial Inclusion Criteria,"Inclusion Criteria: Male or Female, age 18-65,Asian.",ct_inc_387423,AACT,20,NCT02701205,Asian,asian
5bd264775d72d24d0eec4dfc,223075,-1,55,2018-10-26 00:48:55.549000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_441249,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male subject of Caucasian origin 18 to 45 years of age (inclusive).,ct_inc_441249,AACT,30,NCT01998672,Caucasian,white
5bd264775d72d24d0eec4dfd,223075,-1,55,2018-10-26 00:48:55.611000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_441250,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy male subject of caucasian origin 18 to 45 years of age - Good state of health (mentally and physically) as determined by medical history, physical examination, vital signs, ECG recording and clinical lab results.",ct_inc_441250,AACT,30,NCT01998659,caucasian,white
5bd265275d72d25127ec4dfc,248325,-1,54,2018-10-26 00:51:51.522000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_572634,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Community living Caucasian woman 65 years; live expectation,ct_inc_572634,AACT,39,NCT00267839,Caucasian,white
5bd265f95d72d25620ec4dfc,65325,-1,92,2018-10-26 00:55:21.213000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_365326,Clinical Trial Inclusion Criteria,- Black African Caribbean or African (defined as a person having origins in any of the black racial groups of Africa).,ct_inc_365326,AACT,51,NCT02989207,black,black
5bd266215d72d25727ec4dfc,160950,-1,22,2018-10-26 00:56:01.738000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_446475,Clinical Trial Inclusion Criteria,- Asian male or female subjects >=20 years of age.,ct_inc_446475,AACT,2,NCT01930383,Asian,asian
5bd266215d72d25707ec4dfc,68225,-1,32,2018-10-26 00:56:01.938000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_436732,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Asian male aged at least 20 years at the time of signing the informed consent form -,ct_inc_436732,AACT,22,NCT02057666,Asian,asian
5bd266a05d72d25a09ec4dfc,81975,-1,16,2018-10-26 00:58:08.971000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_325855,Clinical Trial Inclusion Criteria,- Caucasian male subjects aged 30 to 65 years (inclusive) at Screening. -,ct_inc_325855,AACT,2,NCT03503266,Caucasian,white
5bd2675f5d72d25e30ec4dfc,9150,-1,28,2018-10-26 01:01:19.160000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_420297,Clinical Trial Inclusion Criteria,"African American race Female Gender Age 18-45 years History of sexual activity (oral, vaginal, and/or anal) with a female sexual partner during the past 12 months",ct_inc_420297,AACT,0,NCT02272231,African American,black
5bd267e55d72d2612bec4dfc,49250,-1,58,2018-10-26 01:03:33.054000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_428716,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Japanese or Caucasian subjects between 20-65 years of age,ct_inc_428716,AACT,22,NCT02162355,Caucasian,white
5bd267f45d72d26169ec4dfc,36600,-1,54,2018-10-26 01:03:48.045000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_407831,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Subjects who are male, caucasian, and between 35 and 55 years of age, inclusive.",ct_inc_407831,AACT,39,NCT02434835,caucasian,white
5bd269135d72d2682cec4dfc,32250,-1,52,2018-10-26 01:08:35.996000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_397611,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Be a man or woman of non-Asian origin 18 to 55 years of age,",ct_inc_397611,AACT,27,NCT02568176,Asian,asian
5bd269ad5d72d26bbdec4dfc,19000,-1,46,2018-10-26 01:11:09.415000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_359063,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female caucasian patients 18 years of age - Diagnosis of high myopia secondary to an anterior-posterior elongation of the bulbus confirmed by ocular examination in either eye using the following criteria: - Ocular ultrasonography or biometry demonstrating anterior-posterior elongation measurement 26 mm - abnormal change in retinal tissue by SD-OCT that are attributed to be caused by high myopia as shown in Table 4-2 of the protocol in the investigator's discretion confirmed by the reading centre,ct_inc_359063,AACT,22,NCT03070717,caucasian,white
5bd269ba5d72d26c20ec4dfc,65125,-1,30,2018-10-26 01:11:22.523000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_372602,Clinical Trial Inclusion Criteria,All subjects -- Male and white subjects between 45 and 79 years of age with a body mass index between 18 to 34 kg/m*2 (both inclusive).,ct_inc_372602,AACT,16,NCT02894385,white,white
5bd26a4b5d72d26f73ec4dfc,177650,-1,44,2018-10-26 01:13:47.644000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_524273,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - healthy male Caucasian volunteers aged 18-40 years,",ct_inc_524273,AACT,30,NCT00909701,Caucasian,white
5bd26a5e5d72d26fddec4dfc,171125,-1,38,2018-10-26 01:14:06.133000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_460195,Clinical Trial Inclusion Criteria,"Far -East Asian is defined as a person of self-reported Asian ancestry including that of Japanese, Korean or Chinese descent (which includes Taiwanese subjects) [for Part B only].",ct_inc_460195,AACT,10,NCT01751074,Asian,asian
5bd26aab5d72d2718eec4dfc,89900,-1,194,2018-10-26 01:15:23.641000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_314714,Clinical Trial Inclusion Criteria,Inclusion Criteria: Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study Male or female black African aged 18 years or older,ct_inc_314714,AACT,174,NCT03648229,black,black
5bd26ace5d72d2726dec4dfc,112950,-1,36,2018-10-26 01:15:58.252000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_563663,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male Caucasian subjects, aged 18 - 55 years - BMI between 18 and 30 kg/m2 inclusive, with a lover limit of body weight of 50 kg - Subjects must be in good health as determined by medical history, physical examination, 12-lead electrocardiogram, vital signs, and clinical laboratory parameters - Subjects giving written informed consent to participate within this trial",ct_inc_563663,AACT,22,NCT00387777,Caucasian,white
5bd26b5c5d72d27577ec4dfc,176450,-1,40,2018-10-26 01:18:20.679000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_528330,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male white subjects - 18 to 45 years of age - BMI between 18 and 28 kg/m2 - Subjects who are able to understand and follow instructions and who are able to participate in the study for the entire period,ct_inc_528330,AACT,30,NCT00855660,white,white
5bd26c875d72d27bd7ec4dfc,234225,-1,194,2018-10-26 01:23:19.396000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_530199,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - A person who has been diagnosed with acute coronary syndrome (ACS) and is to undergo a percutaneous coronary intervention (PCI) - A person who is of East or Southeast Asian descent - A person who is of the legal age of 18 (or age 21 in Singapore) and is mentally competent to provide a signed written informed consent before entering the study - If a woman is of childbearing potential, she must test negative for pregnancy and agree to use a reliable method of birth control",ct_inc_530199,AACT,154,NCT00830960,Asian,asian
5bd26c8a5d72d27be2ec4dfc,213300,-1,92,2018-10-26 01:23:22.198000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_487915,Clinical Trial Inclusion Criteria,"Inclusion Criteria: Adults (age 18 to 65 years of age), male or female Hispanic or Caucasian.",ct_inc_487915,AACT,56,NCT01387659,Caucasian,white
5bd26cc95d72d27d63ec4dfc,205400,-1,43,2018-10-26 01:24:25.277000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_532727,Clinical Trial Inclusion Criteria,Caucasian male or clinically sterile female subjects 2.,ct_inc_532727,AACT,0,NCT00797706,Caucasian,white
5bd270895d72d213e5ec4dfc,10375,-1,64,2018-10-26 01:40:25.656000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_413982,Clinical Trial Inclusion Criteria,The participant is a healthy adult male of Japanese or Caucasian (born to Caucasian parents and grandparents).,ct_inc_413982,AACT,35,NCT02354599,Caucasian,white
5bd2709f5d72d21469ec4dfc,206700,-1,22,2018-10-26 01:40:47.724000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_475190,Clinical Trial Inclusion Criteria,"Healthy male Caucasian subject, aged between 18 and 45 years (inclusive), assessed as healthy based on a screening examination including medical history without clinically relevant pathologies, physical examination, vital signs, ECG assessment, pulmonary function testing, and clinical laboratory results.",ct_inc_475190,AACT,8,NCT01554319,Caucasian,white
5bd270d55d72d2157cec4dfc,197000,-1,44,2018-10-26 01:41:41.318000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_536119,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male Caucasian subjects.,ct_inc_536119,AACT,30,NCT00752830,Caucasian,white
5bd270fe5d72d21684ec4dfc,90675,-1,213,2018-10-26 01:42:22.144000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_313305,Clinical Trial Inclusion Criteria,Inclusion Criteria: Patients with non-insulin requiring diabetes mellitus type 2 treated with diet and oral antidiabetics and/or Glucagon-like Peptide 1 receptor agonists Age: 18-75 years Female and male Caucasian 5.,ct_inc_313305,AACT,188,NCT03666546,Caucasian,white
5bd271375d72d217caec4dfc,185325,-1,83,2018-10-26 01:43:19.539000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_516989,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy non-Asian, male or non-lactating, non-pregnant female participants who are 18-65 years of age.",ct_inc_516989,AACT,34,NCT01005719,Asian,asian
5bd271805d72d2197bec4dfc,129775,-1,43,2018-10-26 01:44:32.180000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_434700,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male and female white subjects between 18-79 years of age (inclusive) - Subjects must have a BMI between 18-34 kg/m, inclusive - Part 1, Group 1: subject with severe renal impairment or ESRD, not on dialysis : eGFR between 15-29 mL",ct_inc_434700,AACT,22,NCT02084199,white,white
5bd272535d72d21e14ec4dfc,216500,-1,157,2018-10-26 01:48:03.712000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_550133,Clinical Trial Inclusion Criteria,"At least ONE of the following patient characteristics: previously detected deletion 19 or L858R EGFR mutation, female sex, history of never smoking, or Asian/Pacific Rim ethnicity (to be enrolled in the screening portion of trial).",ct_inc_550133,AACT,111,NCT00567359,Asian,asian
5bd272675d72d21e8dec4dfc,54400,-1,84,2018-10-26 01:48:23.754000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_424674,Clinical Trial Inclusion Criteria,"- White/Caucasian/European and Asian/East Asian heritage individuals, male or female, 18 years of age or older.",ct_inc_424674,AACT,42,NCT02215174,Asian,asian
5bd272d65d72d220f5ec4dfc,198425,-1,25,2018-10-26 01:50:14.924000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_530926,Clinical Trial Inclusion Criteria,Male and Female Caucasian patients aged 18-45 years who have provided written informed consent.,ct_inc_530926,AACT,0,NCT00821457,Caucasian,white
5bd273365d72d2230cec4dfc,213400,-1,43,2018-10-26 01:51:50.683000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_497092,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male or female, Asian-American, who have participated and completed the study, qualify the following criteria, and remain on TDF treatment without severe treatment-related AEs, and with available retrospective lab results as summarized in Appendix 2.",ct_inc_497092,AACT,22,NCT01267162,Asian,asian
5bd274115d72d224a2ec4dfc,232300,-1,22,2018-10-26 01:55:29.835000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_576912,Clinical Trial Inclusion Criteria,"Male citizens of Asian countries and Australia are encouraged to enroll in the study - patient is in a stable, monogamous sexual relationship with the same woman for at least 6 months and plans to maintain this relationship for the duration of the study - diagnosis of premature ejaculation (PE) according to the criteria of Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) for at least 6 months before study initiation - history of intravaginal ejaculatory latency time",ct_inc_576912,AACT,0,NCT00210704,Asian,asian
5bd277195d72d227b4ec4dfc,178725,-1,31,2018-10-26 02:08:25.221000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_525864,Clinical Trial Inclusion Criteria,Subject is an Asian Indian male between 18 to 45 years of age - Subject is in good health - Subject is a nonsmoker or has not used nicotine-containing products for six months - Subject is willing to avoid strenuous activity,ct_inc_525864,AACT,14,NCT00888238,Asian,asian
5bd278d65d72d22994ec4dfc,22925,-1,68,2018-10-26 02:15:50.352000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_368156,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Must be male and self-reported American Indian; Reside in or near Colville tribe; ages 21-65, A BMI 25 kg/m2",ct_inc_368156,AACT,30,NCT02952352,American Indian,american indian
5bd279995d72d22a1cec4dfc,9725,-1,16,2018-10-26 02:19:05.015000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_442939,Clinical Trial Inclusion Criteria,- Caucasian male subjects aged 18 to 50 years inclusive.,ct_inc_442939,AACT,2,NCT01976572,Caucasian,white
5bd27d7d5d72d22ebcec4dfc,9950,-1,44,2018-10-26 02:35:41.510000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_420856,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian healthy male subjects - Body mass index (BMI) 19 to 25 kg/m2 - Informed consent,ct_inc_420856,AACT,22,NCT02264951,Caucasian,white
5bd27ea15d72d22f8eec4dfc,178525,-1,46,2018-10-26 02:40:33.590000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_518931,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Caucasians aged between 18 and 65 years - Patients with mild AD presenting a scoring AD (SCORAD) rating between 3-25 - Skin type I - IV according to Fitzpatrick - Acute AD symptoms on each assessment areas (local SCORAD >/=3 and <= 12) - Acute symptom of pruritus at Baseline,ct_inc_518931,AACT,22,NCT00980135,Caucasian,white
5bd283395d72d23426ec4dfc,137025,-1,27,2018-10-26 03:00:09.461000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_482648,Clinical Trial Inclusion Criteria,"- Male and female Caucasian subjects - Group 1, 2 and 3 (subjects with hepatic impairment)",ct_inc_482648,AACT,2,NCT01456663,Caucasian,white
5bd28a455d72d23b5eec4dfc,131200,-1,48,2018-10-26 03:30:13.133000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_477502,Clinical Trial Inclusion Criteria,"East Asian or Caucasian subjects, male or female, and 18 to 65 years of age inclusive - Body mass index (BMI) in the range of 19.0 to 30.0 kg/m2 and body weight 50 kg inclusive - In generally good physical and mental health status on the basis of a medical history review, medical evaluation including vital signs and physical examination, 12-lead ECG, and laboratory results at screening - For females, one of the following criteria must be fulfilled: At least 1 year post menopausal, or Surgically sterile, or Willing to use a double barrier method [intrauterine device (IUD) plus condom, spermicidal gel plus condom] of contraception from screening until 30 days after the last dose of study drug - Males must be willing to use a reliable form of contraception (use of a condom or a partner fulfilling the above criteria) from screening until 30 days after the last dose of study drug - Willing to abstain from caffeine- or xanthine-containing beverages, including coffee and tea, alcohol, grapefruit juice, and Seville oranges during the stay-on-site period - Willing and able to provide written informed consent",ct_inc_477502,AACT,5,NCT01523990,Asian,asian
5bd28a5d5d72d23c1dec4dfc,166250,-1,24,2018-10-26 03:30:37.065000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_471048,Clinical Trial Inclusion Criteria,- trained male caucasian cyclists - Non-smokers -,ct_inc_471048,AACT,10,NCT01608529,caucasian,white
5bd28bcd5d72d23de0ec4dfc,161375,-1,46,2018-10-26 03:36:45.799000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_445082,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian healthy female subjects, - complaining vaginal dryness, - women in menopause since at least 2 years; the starting period of menopause being defined as the date when the last menstruation or metrorragia linked to hormonal unbalance took place, - women who agree not to start a replacement therapy during the whole duration of the study, - women who do not present any active cutaneous pathology of external and internal genitalia, - women who did not receive any drug or cosmetic treatment on their genitalia during the 2 months preceding the trial, - women who did not apply vaginal products within at least 1 month before the inclusion in the study, - women who accept to use only the products authorised by the protocol, - women who accept not to undertake any treatment for internal and external genitalia during the trial, - women who did not use, phytoestrogenes based products on treated areas less than 4 weeks before inclusion time, - women accepting to sign the Informed consent form, - women able to read the material dedicated to volunteers, to abide by the rules of the protocol and ready to accept its constraints",ct_inc_445082,AACT,22,NCT01948583,Caucasian,white
5bd28cc25d72d23ea6ec4dfc,133550,-1,46,2018-10-26 03:40:50.424000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_461133,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian male or female between 18 and 65 years of age inclusive, at the time of signing the informed consent - BMI in the normal range or greater, which is equal to 22 kilogram (kg) per meter square (m^2) or above, but otherwise healthy as determined by a responsible and experienced physician, based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring.",ct_inc_461133,AACT,22,NCT01738867,Caucasian,white
5bd28ef35d72d24039ec4dfc,29350,-1,90,2018-10-26 03:50:11.410000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_382538,Clinical Trial Inclusion Criteria,"HIV-positive Identify as Black and/or African American Age 18 or older Biologically female English speaking Prescribed ART medication for at least the last two months Low ART adherence (<80%) or detectable viral load within the past six months or History of abuse/trauma (e.g. sexual, physical, and/or emotional abuse, experienced a traumatic event) Capable of completing and fully understanding the informed consent process and the study procedures",ct_inc_382538,AACT,38,NCT02764853,African American,black
5bd2928a5d72d2445cec4dfc,53025,-1,44,2018-10-26 04:05:30.501000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_430481,Clinical Trial Inclusion Criteria,Child is an American Indian or Alaska Native living on or near the Tribe's reservation.,ct_inc_430481,AACT,0,NCT02139332,Alaska Native,alaska native
5bd293aa5d72d24584ec4dfc,22575,-1,67,2018-10-26 04:10:18.317000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_367315,Clinical Trial Inclusion Criteria,"Inclusion criteria - Age 18-65 years old - Caucasian male or female volunteers - Body mass index (BMI) 18-30 kg/m2, weight 50 kg - Full mental and legal capacity - Signed informed consent prior to any study related procedure - Ability to communicate in German or English, sufficient to comprehend and adhere to study protocol - Normal physical examination, vital signs, laboratory workup, and electrocardiogram (ECG)",ct_inc_367315,AACT,43,NCT02963324,Caucasian,white
5bd298705d72d24a82ec4dfc,15125,-1,63,2018-10-26 04:30:40.598000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_364293,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Dutch South Asian or white Caucasian male, 20-30 years - BMI 18 and 25 kg/m2 - Good general health",ct_inc_364293,AACT,34,NCT03002675,Asian,asian
5bd29be35d72d24e18ec4dfc,11800,-1,23,2018-10-26 04:45:23.188000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_413893,Clinical Trial Inclusion Criteria,Subject is a white male 18 and 45 years of age.,ct_inc_413893,AACT,13,NCT02355756,white,white
5bd29be95d72d24e29ec4dfc,146850,-1,32,2018-10-26 04:45:29.568000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_513715,Clinical Trial Inclusion Criteria,In European arms of study female patients must be without childbearing potential.,ct_inc_513715,AACT,3,NCT01049399,European,white
5bd29d025d72d24eebec4dfc,101675,-1,161,2018-10-26 04:50:10.387000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_320211,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Successful prior completion of related protocol CLEAR (NCT02937350) or CLEAR-CF (NCT03104855) - Age 18 years - Self-reported race Caucasian, African American, or African",ct_inc_320211,AACT,147,NCT03576716,Caucasian,white
5bd2a09e5d72d252f5ec4dfc,131325,-1,44,2018-10-26 05:05:34.353000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_481061,Clinical Trial Inclusion Criteria,Inclusion Criteria: Age 18 - 75 Female White race/ethnicity With history of non-melanoma skin cancer,ct_inc_481061,AACT,32,NCT01477463,White,white
5bd2a4325d72d256c8ec4dfc,206925,-1,46,2018-10-26 05:20:50.379000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_476997,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Male or female Caucasian patients aged 18 and 70 years -,ct_inc_476997,AACT,22,NCT01530620,Caucasian,white
5bd2a9fd5d72d25c5aec4dfc,155300,-1,47,2018-10-26 05:45:33.109000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_448934,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Filipino and Asian female subjects from private clinics of a tertiary hospital in the Philippines older than 35 years of age and less than 65 years of age.,ct_inc_448934,AACT,35,NCT01898182,Asian,asian
5bd2aa075d72d25c95ec4dfc,198000,-1,22,2018-10-26 05:45:43.642000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_538323,Clinical Trial Inclusion Criteria,African American child age 9-12 with family history of type 2 diabetes in a first or second degree relative.,ct_inc_538323,AACT,0,NCT00723853,African American,black
5bd2aeac5d72d2612aec4dfc,182675,-1,46,2018-10-26 06:05:32.542000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_526670,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian male or female out-patients; - aged 18 to 75 years inclusive; - diagnosis of probable or definite amyotrophic lateral sclerosis according to the El Escorial revised criteria (1); - first symptoms of ALS by no more than 1.5 years; - in treatment with steady regimen of riluzole for a minimum of 3 months before study entry, and desiring its continuation; - FVC 75% of predicted; - no conditions known to be contraindications to the use of TUDCA; - written informed consent.",ct_inc_526670,AACT,22,NCT00877604,Caucasian,white
5bd2afc25d72d261a7ec4dfc,138450,-1,22,2018-10-26 06:10:10.477000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_481563,Clinical Trial Inclusion Criteria,"Healthy male Caucasian subject - healthy based on a screening examination including medical history, without clinically relevant pathologies, physical examination, vital signs, ECG assessment, pulmonary function testing, and clinical laboratory results.",ct_inc_481563,AACT,8,NCT01470911,Caucasian,white
5bd2b1095d72d263a1ec4dfc,100550,-1,49,2018-10-26 06:15:37.381000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_351533,Clinical Trial Inclusion Criteria,"18-90 years old, male or female, African American (AA) or White; Stage 1 or 2 pre-hypertensive (i.e., SBP 120-139/DBP<90) based upon 2 consecutive clinic evaluations; Body Mass Index (BMI) 18.5 -45 Kg/m2; 4. legally competent; 5. able to use a smart phone.",ct_inc_351533,AACT,17,NCT03168789,African American,black
5bd2b3555d72d265b3ec4dfc,134650,-1,51,2018-10-26 06:25:25.621000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_461330,Clinical Trial Inclusion Criteria,"Any woman who identifies as African American, Black, or African - Currently nursing a baby - Able and willing to sign written informed consent - Willing to be contacted by study personnel for follow-up to determine whether a biopsy took place - Willing to have her milk sample archived for future analyses",ct_inc_461330,AACT,4,NCT01736306,Black,black
5bd2b59e5d72d26774ec4dfc,37525,-1,55,2018-10-26 06:35:10.501000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_410762,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American or Latina female and sexually active with a male,ct_inc_410762,AACT,22,NCT02396602,African American,black
5bd2b6ce5d72d268e3ec4dfc,64500,-1,107,2018-10-26 06:40:14.786000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_372153,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Able to provide written informed consent to participate in the study - Caucasian male aged at least 35 years at Screening - Healthy and free from clinically significant illness or disease at Screening and Day-1 - A body weight of 60 to 110 kg at Screening and,ct_inc_372153,AACT,93,NCT02900235,Caucasian,white
5bd2b6e45d72d26981ec4dfc,178950,-1,62,2018-10-26 06:40:36.671000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_526413,Clinical Trial Inclusion Criteria,"Diagnosis of breast cancer African American or Hispanic female Receiving treatment at LBJ General Hospital, Ben Taub Hospital, or M.D. Anderson Cancer Center",ct_inc_526413,AACT,27,NCT00881010,African American,black
5bd2ba505d72d26d21ec4dfc,247175,-1,45,2018-10-26 06:55:12.742000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_560424,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male or female Europeans aged 18 years or older with moderate to severe HTN, defined as follows (conventional BP measurements)",ct_inc_560424,AACT,22,NCT00430950,European,white
5bd2babe5d72d26e63ec4dfc,96450,-1,28,2018-10-26 06:57:02.493000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_344624,Clinical Trial Inclusion Criteria,- Japanese or Caucasian male.,ct_inc_344624,AACT,14,NCT03258762,Caucasian,white
5bd2c0e25d72d2740cec4dfc,178625,-1,36,2018-10-26 07:23:14.733000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_525740,Clinical Trial Inclusion Criteria,Subject has to: 1. be Caucasian male 2.,ct_inc_525740,AACT,22,NCT00889850,Caucasian,white
5bd2c3b35d72d276a8ec4dfc,24550,-1,37,2018-10-26 07:35:15.177000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_390487,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male, Caucasian volunteers, deemed healthy on the basis of a clinical history, physical examination, ECG, vital signs, and laboratory tests of blood and urine.",ct_inc_390487,AACT,22,NCT02661178,Caucasian,white
5bd2c3d85d72d27736ec4dfc,9925,-1,103,2018-10-26 07:35:52.703000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_420832,Clinical Trial Inclusion Criteria,"Study Group (Berlin/Utrecht): Inclusion Criteria: - Male and female patients aged 65 years, of European descent (Caucasian) - Elective surgery with an expected operative time 60 minutes - Ability to give informed consent after receiving spoken and written information of the study - Eligibility for magnetic resonance Imaging",ct_inc_420832,AACT,61,NCT02265263,European,white
5bd2c4e45d72d277e7ec4dfc,53325,-1,55,2018-10-26 07:40:20.223000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_430580,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Abile person of Northern European descent - Age between 18 to 65 years -,ct_inc_430580,AACT,28,NCT02138045,European,white
5bd2cad15d72d27de6ec4dfc,78100,-1,43,2018-10-26 08:05:37.438000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_327542,Clinical Trial Inclusion Criteria,Inclusion Criteria: - African American male adults,ct_inc_327542,AACT,22,NCT03481270,African American,black
5bd2cd125d72d27f85ec4dfc,226950,-1,80,2018-10-26 08:15:14.172000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_467697,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Male and female human subjects, age 18-45 years, Caucasians - Body weight of at least 50 kg, maximum of 90 kg.",ct_inc_467697,AACT,31,NCT01652898,Caucasian,white
5bd2d4315d72d20880ec4dfc,240475,-1,81,2018-10-26 08:45:37.654000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_557053,Clinical Trial Inclusion Criteria,"Inclusion criteria: - Healthy Caucasian male subjects or healthy Caucasian female subjects of non-childbearing potential - Aged between 18-55 years - Non-smokers - Normal spirometry (FEV1 = 80% of predicted, FEV1/FVC = 70%) -",ct_inc_557053,AACT,30,NCT00475436,Caucasian,white
5bd2d9f25d72d20dddec4dfc,110625,-1,293,2018-10-26 09:10:10.010000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_565400,Clinical Trial Inclusion Criteria,"Subject has NSCLC with a histologically confirmed diagnosis of adenocarcinoma with measurable disease (stage IIIB, with malignant pleural effusion, and stage IV) and either has a demonstrated activating mutation of the EGF receptor in tumor tissue or meets one of three criteria: asian, female, and minimal or no smoking history.",ct_inc_565400,AACT,280,NCT00364780,asian,asian
5bd2db235d72d20efbec4dfc,131825,-1,47,2018-10-26 09:15:15.374000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_480555,Clinical Trial Inclusion Criteria,"The subjects must be female, dark eye Caucasian, Non-Hispanic habitual soft contact lens wearer (both eyes).",ct_inc_480555,AACT,21,NCT01484054,Caucasian,white
5bd2db235d72d20efbec4dfd,131825,-1,48,2018-10-26 09:15:15.855000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_480557,Clinical Trial Inclusion Criteria,"The subjects must be female, light eye Caucasian, Non-Hispanic, habitual soft contact lens wearer (both eyes) with light or dark eyes - Must have rated the Concept Statement positively (i.e., a rating of 4 or 5).",ct_inc_480557,AACT,21,NCT01484028,Caucasian,white
5bd2dd785d72d211bbec4dfc,37400,-1,36,2018-10-26 09:25:12.997000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_402434,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Caucasian male volunteers - Physically and mentally healthy as judged by means of a medical and standard laboratory examination - BMI of between 19 and 29 kg/m2,",ct_inc_402434,AACT,22,NCT02505191,Caucasian,white
5bd2df565d72d21402ec4dfc,72350,-1,36,2018-10-26 09:33:10.201000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_337742,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Caucasian male between 20 and 50 years of age - Body mass index (BMI) between 19 and 25 kg/m2 - Weekly alcohol intake of less than 14 units of alcohol (of 12 g) -,ct_inc_337742,AACT,22,NCT03348371,Caucasian,white
5bd2eb875d72d21fc4ec4dfc,139875,-1,41,2018-10-26 10:25:11.461000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_475872,Clinical Trial Inclusion Criteria,"- A male or female American Indian infant between, and including, 6 and 12 weeks (42-90 days) of age at the time of the first vaccination.",ct_inc_475872,AACT,19,NCT01545375,American Indian,american indian
5bd2ef285d72d22476ec4dfc,75975,-1,120,2018-10-26 10:40:40.955000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_331477,Clinical Trial Inclusion Criteria,"To be eligible for the study, adolescent sons must: 1. be 15 to 19 year old male, 2. identify as either African American or Latino, 3.",ct_inc_331477,AACT,76,NCT03429985,African American,black
5bd2f0375d72d224c3ec4dfc,9275,-1,31,2018-10-26 10:45:11.067000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_421197,Clinical Trial Inclusion Criteria,White or African American woman - Overweight or obese (prepregnancy,ct_inc_421197,AACT,0,NCT02260518,White,white
5bd2f1645d72d22641ec4dfc,52925,-1,57,2018-10-26 10:50:12.606000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_429964,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male Japanese and Caucasian subjects - Age between 20 and 55 years (both inclusive),ct_inc_429964,AACT,30,NCT02146079,Caucasian,white
5bd2f17b5d72d226b7ec4dfc,9100,-1,44,2018-10-26 10:50:35.754000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_420738,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male caucasian subjects as determined by results of screening - Written informed consent in accordance with good clinical practice (GCP) and local legislation - Age 18 and 50 years - Broca - 20 % and + 20 %,ct_inc_420738,AACT,30,NCT02266498,caucasian,white
5bd2f17c5d72d226b7ec4dfd,9100,-1,44,2018-10-26 10:50:36.082000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_420739,Clinical Trial Inclusion Criteria,Inclusion Criteria: - Healthy male caucasian subjects as determined by results of screening - Written informed consent in accordance with good clinical practice (GCP) and local legislation given - Age 18 and 65 years - Broca - 20 % and +,ct_inc_420739,AACT,30,NCT02266485,caucasian,white
5bd2f2d15d72d228adec4dfc,224250,-1,44,2018-10-26 10:56:17.188000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_456615,Clinical Trial Inclusion Criteria,"Inclusion Criteria: - Healthy male Caucasian subjects with skin type I-III inclusive (Fitzpatrick Scale), between the ages of 18 and 55 years, inclusive (Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and pulse rate measurement, 12 lead ECG and clinical laboratory tests).",ct_inc_456615,AACT,30,NCT01797796,Caucasian,white
5bd2f5045d72d22ab2ec4dfc,203450,-1,44,2018-10-26 11:05:40.806000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_541514,Clinical Trial Inclusion Criteria,Inclusion Criteria: - European American male and females between 21-27 years of age.,ct_inc_541514,AACT,22,NCT00681655,European,white
5bd2fbdc5d72d23180ec4dfc,17900,-1,129,2018-10-26 11:34:52.333000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_361377,Clinical Trial Inclusion Criteria,"Participants of Japanese origin, with Japanese parents (for the provisional Caucasian cohort, participants must be male or female Caucasians with 4 Caucasian grand-parents) -",ct_inc_361377,AACT,76,NCT03040635,Caucasian,white
5bd300b85d72d236e6ec4dfc,248900,-1,66,2018-10-26 11:55:36.431000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_574144,Clinical Trial Inclusion Criteria,Self-reported White/Caucasian or Black/African American individual who have participated in the protocol #148 (90-DA-N448) in order to obtain the molecular genetic variables needed in the current study.,ct_inc_574144,AACT,39,NCT00247689,African American,black
5bd305705d72d23bf1ec4dfc,57450,-1,80,2018-10-26 12:15:44.708000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_389406,Clinical Trial Inclusion Criteria,Healthy and free from clinically significant illness or disease - Male Caucasian subjects aged 18 to 55 - A body weight of 60 kg,ct_inc_389406,AACT,66,NCT02675309,Caucasian,white
5bd306965d72d23d04ec4dfc,162925,-1,58,2018-10-26 12:20:38.205000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_443335,Clinical Trial Inclusion Criteria,Inclusion Criteria: Age 70 or older woman African American ethnicity Non-institutionalized,ct_inc_443335,AACT,36,NCT01971411,African American,black
5bd308d25d72d23e7dec4dfc,133675,-1,40,2018-10-26 12:30:10.160000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_461273,Clinical Trial Inclusion Criteria,Either by male to male exposure if white or by heterosexual exposure if white or black African - able to comprehend study patient information leaflet -Younger HIV-positive cohort (n=500): - documented HIV infection - age <50 at study entry* - self defined white or black African ethnicity - likely route of HIV acquisition via sexual exposure,ct_inc_461273,AACT,10,NCT01737047,white,white
5bd30b2c5d72d24141ec4dfc,208750,-1,221,2018-10-26 12:40:12.288000,652,RaceFinderFunction,claritynlp,True,875,RaceFinderTask,2018-10-25T00:00:00Z,ct_inc_486537,Clinical Trial Inclusion Criteria,Participants must be age 50 years or older - Participants must have a working telephone (a necessary criterion since much of the interventions are telephone based) - Self-identified as a black or African American and male - Have uncontrolled hypertension defined as SBP>135 mmHg or DBP>85 mmHg and SBP,ct_inc_486537,AACT,187,NCT01405638,black,black
